| Code | Display | Comments |
|---|
 10000-8 | R wave duration in lead AVR | |
| 100000-9 | Health informatics pioneer and the father of LOINC | |
| 100001-7 | Health informatics pioneer and cofounder of LOINC | |
| 10001-6 | R wave duration in lead I | |
| 100018-1 | Hospice care Note | |
| 10002-4 | R wave duration in lead II | |
| 10003-2 | R wave duration in lead III | |
| 100034-8 | Provider of automated external defibrillator use | |
| 100035-5 | Exam finding location of Chest | |
| 100036-3 | Exam finding location of Lung | |
| 100037-1 | Patient contact disposition EMS unit | |
| 100038-9 | Patient evaluation disposition EMS unit | |
| 100039-7 | Crew disposition for patient care EMS unit | |
| 10004-0 | R wave duration in lead V1 | |
| 100040-5 | Patient transport disposition EMS unit | |
| 10005-7 | R wave duration in lead V2 | |
| 10006-5 | R wave duration in lead V3 | |
| 100062-9 | Standard Dermatology Outcome Measures panel | |
| 100063-7 | Primary skin concern | |
| 100064-5 | Itch severity Reporting Period - Reported | |
| 100065-2 | Satisfied with treatment | |
| 100066-0 | Specular microscopy panel | |
| 100067-8 | Eye Image magnification | |
| 100068-6 | Right eye Fixation point [Angle] | |
| 100069-4 | Left eye Fixation point [Angle] | |
| 10007-3 | R wave duration in lead V4 | |
| 100070-2 | Right cornea Cell density | |
| 100071-0 | Left cornea Cell density | |
| 100072-8 | Right cornea Coefficient of variation | |
| 100073-6 | Left cornea Coefficient of variation | |
| 100074-4 | Right cornea Hexagonality | |
| 100075-1 | Left cornea Hexagonality | |
| 100076-9 | Right cornea Endothelial cells counted | |
| 100077-7 | Left cornea Endothelial cells counted | |
| 100078-5 | Right cornea Endothelial cell area.min | |
| 100079-3 | Left cornea Endothelial cell area.min | |
| 10008-1 | R wave duration in lead V5 | |
| 100080-1 | Right cornea Endothelial cell area.max | |
| 100081-9 | Left cornea Endothelial cell area.max | |
| 100082-7 | Right cornea Endothelial cell area.mean | |
| 100083-5 | Left cornea Endothelial cell area.mean | |
| 100084-3 | Right cornea Cell area.standard deviation | |
| 100085-0 | Left cornea Cell area.standard deviation | |
| 100086-8 | Right cornea Type of Analysis method by Specular microscopy | |
| 10009-9 | R wave duration in lead V6 | |
| 10010-7 | R' wave amplitude in lead AVF | |
| 10011-5 | R' wave amplitude in lead AVL | |
| 10012-3 | R' wave amplitude in lead AVR | |
| 10013-1 | R' wave amplitude in lead I | |
| 10014-9 | R' wave amplitude in lead II | |
| 10015-6 | R' wave amplitude in lead III | |
| 100155-1 | Left cornea Type of Analysis method by Specular microscopy | |
| 10016-4 | R' wave amplitude in lead V1 | |
| 100160-1 | Knee replacement | |
| 100161-9 | Charnley Functional Classification | |
| 100162-7 | Knee alignment W standing X-ray measured | |
| 100163-5 | Knee medial AndOr lateral instability W full extension | |
| 100164-3 | Knee AP instability W 90 degree flexion | |
| 100165-0 | Knee range of motion | |
| 100166-8 | Flexion contracture range of Knee | |
| 100167-6 | Extensor lag range of Knee | |
| 10017-2 | R' wave amplitude in lead V2 | |
| 10018-0 | R' wave amplitude in lead V3 | |
| 10019-8 | R' wave amplitude in lead V4 | |
| 10020-6 | R' wave amplitude in lead V5 | |
| 10021-4 | R' wave amplitude in lead V6 | |
| 100214-6 | Dental model prior authorization Document | |
| 100215-3 | Episode of care medical records Document Transplant surgery | |
| 100216-1 | Surgical synoptic report | |
| 100217-9 | Surgical oncology synoptic report | |
| 100218-7 | Surgical oncology of colon synoptic report | |
| 100219-5 | Surgical oncology of melanoma synoptic report | |
| 10022-2 | R' wave duration in lead AVF | |
| 100220-3 | Surgical oncology of breast synoptic report | |
| 100221-1 | Surgical oncology of thyroid synoptic report | |
| 100222-9 | Surgical oncology of pancreas synoptic report | |
| 100223-7 | Physical findings of Retina Narrative | |
| 100224-5 | Cardiac left ventricular segmental wall motion by echo panel | |
| 100225-2 | Bone density quantitative ultrasound study | |
| 100226-0 | Small bowel capsule endoscopy study Document | |
| 100227-8 | Colon capsule endoscopy study Document | |
| 100228-6 | Upper gastrointestinal capsule endoscopy study Document | |
| 100229-4 | Endoscopic ultrasound study Document | |
| 10023-0 | R' wave duration in lead AVL | |
| 100230-2 | Routine prenatal assessment panel | |
| 100231-0 | Endobronchial ultrasound study | |
| 10024-8 | R' wave duration in lead AVR | |
| 10025-5 | R' wave duration in lead I | |
| 100256-7 | Fallen in last 6 months | |
| 100257-5 | Feel unsteady when standing or walking | |
| 100258-3 | History of fall related injury | |
| 10026-3 | R' wave duration in lead II | |
| 10027-1 | R' wave duration in lead III | |
| 10028-9 | R' wave duration in lead V1 | |
| 100282-3 | Vaccine exemption certificate | |
| 10029-7 | R' wave duration in lead V2 | |
| 100298-9 | Repetition count | |
| 10030-5 | R' wave duration in lead V3 | |
| 100300-3 | End time Unspecified body region | |
| 100301-1 | Start time Unspecified body region | |
| 100302-9 | Time period start and end panel Unspecified body region | |
| 100303-7 | Condition certainty of presence | |
| 100304-5 | Flights climbed [#] Reporting Period | |
| 10031-3 | R' wave duration in lead V4 | |
| 10032-1 | R' wave duration in lead V5 | |
| 10033-9 | R' wave duration in lead V6 | |
| 10034-7 | S wave amplitude in lead AVF | |
| 100348-2 | Model for end-stage liver disease sodium score | |
| 100349-0 | US.doppler Penis vessels W vasodilator IV | |
| 10035-4 | S wave amplitude in lead AVL | |
| 10036-2 | S wave amplitude in lead AVR | |
| 100369-8 | NM Thyroid gland Views W Tl-201 IV | |
| 10037-0 | S wave amplitude in lead I | |
| 10038-8 | S wave amplitude in lead II | |
| 100382-1 | FDA package insert REMS addressed risk | |
| 10039-6 | S wave amplitude in lead III | |
| 10040-4 | S wave amplitude in lead V1 | |
| 10041-2 | S wave amplitude in lead V2 | |
| 10042-0 | S wave amplitude in lead V3 | |
| 10043-8 | S wave amplitude in lead V4 | |
| 100438-1 | Adolescent medicine Outpatient Progress note | |
| 100439-9 | Allergy and Immunology Outpatient Progress note | |
| 10044-6 | S wave amplitude in lead V5 | |
| 100440-7 | Allergy Outpatient Progress note | |
| 100441-5 | Attending Outpatient Progress note | |
| 100442-3 | Audiology Outpatient Progress note | |
| 100443-1 | Bariatric surgery Outpatient Progress note | |
| 100444-9 | Blood banking and transfusion medicine Outpatient Progress note | |
| 100445-6 | Bone Marrow Transplant Outpatient Progress note | |
| 100446-4 | Breastfeeding Outpatient Progress note | |
| 100447-2 | Burn management Outpatient Progress note | |
| 100448-0 | Cardiac surgery Outpatient Progress note | |
| 100449-8 | Cardiopulmonary Outpatient Progress note | |
| 10045-3 | S wave amplitude in lead V6 | |
| 100450-6 | Child and adolescent psychiatry Outpatient Progress note | |
| 100451-4 | Chiropractic medicine Outpatient Progress note | |
| 100452-2 | Clinical cardiac electrophysiology Outpatient Progress note | |
| 100453-0 | Clinical genetics Outpatient Progress note | |
| 100454-8 | Clinical neurophysiology Outpatient Progress note | |
| 100455-5 | Clinical pathology Outpatient Progress note | |
| 100456-3 | Colon and rectal surgery Outpatient Progress note | |
| 100457-1 | Consultant Outpatient Progress note | |
| 100458-9 | Outpatient COVID-19 Intubation Progress note | |
| 100459-7 | Outpatient COVID-19 Progress note | |
| 10046-1 | S wave duration in lead AVF | |
| 100460-5 | Dermatology Outpatient Progress note | |
| 100461-3 | Developmental-behavioral pediatrics Outpatient Progress note | |
| 100462-1 | Dialysis and Therapeutic apheresis Outpatient Progress note | |
| 100463-9 | Eating disorders Outpatient Progress note | |
| 100464-7 | Endocrinology Outpatient Progress note | |
| 100465-4 | Family medicine Outpatient Progress note | |
| 100466-2 | Gastroenterology Outpatient Progress note | |
| 100467-0 | Geriatric medicine Outpatient Progress note | |
| 100468-8 | Gynecologic oncology Outpatient Progress note | |
| 100469-6 | Gynecology Outpatient Progress note | |
| 10047-9 | S wave duration in lead AVL | |
| 100470-4 | Healthcare navigator Outpatient Progress note | |
| 100471-2 | Heart failure Outpatient Progress note | |
| 100472-0 | Heart failure+Transplant cardiology Outpatient Progress note | |
| 100473-8 | Hematology Outpatient Progress note | |
| 100474-6 | Hematology+Medical oncology Outpatient Progress note | |
| 100475-3 | Hepatology Outpatient Progress note | |
| 100476-1 | Immunology Outpatient Progress note | |
| 100477-9 | Infectious disease Outpatient Progress note | |
| 100478-7 | Internal medicine Outpatient Progress note | |
| 100479-5 | Interventional cardiology Outpatient Progress note | |
| 10048-7 | S wave duration in lead AVR | |
| 100480-3 | Interventional radiology Outpatient Progress note | |
| 100481-1 | Outpatient Mechanical circulatory support Progress note | |
| 100482-9 | Medical Aid in Dying Outpatient Progress note | |
| 100483-7 | Mental health Outpatient Progress note | |
| 100484-5 | Multi-specialty program Outpatient Progress note | |
| 100485-2 | Neonatal perinatal medicine Outpatient Progress note | |
| 100486-0 | Nephrology Outpatient Progress note | |
| 100487-8 | Neurological surgery Outpatient Progress note | |
| 100488-6 | Neurology Outpatient Progress note | |
| 100489-4 | Neurology with special qualifications in child neurology Outpatient Progress note | |
| 10049-5 | S wave duration in lead I | |
| 100490-2 | Nurse practitioner Outpatient Progress note | |
| 100491-0 | Nurse Outpatient Progress note | |
| 100492-8 | Nutrition and dietetics Outpatient Progress note | |
| 100493-6 | Obstetrics and Gynecology Outpatient Progress note | |
| 100494-4 | Obstetrics Outpatient Progress note | |
| 100495-1 | Occupational therapy Outpatient Progress note | |
| 100496-9 | Oncology Outpatient Progress note | |
| 100497-7 | Ophthalmology Outpatient Progress note | |
| 100498-5 | Optometry Outpatient Progress note | |
| 100499-3 | Oral and Maxillofacial Surgery Outpatient Progress note | |
| 10050-3 | S wave duration in lead II | |
| 100500-8 | Orthopaedic surgery Outpatient Progress note | |
| 100501-6 | Orthotics prosthetics Outpatient Progress note | |
| 100502-4 | Otolaryngology Outpatient Progress note | |
| 100503-2 | Pain medicine Outpatient Progress note | |
| 100504-0 | Palliative care Outpatient Progress note | |
| 100505-7 | Pediatric cardiology Outpatient Progress note | |
| 100506-5 | Pediatric dermatology Outpatient Progress note | |
| 100507-3 | Pediatric endocrinology Outpatient Progress note | |
| 100508-1 | Pediatric gastroenterology Outpatient Progress note | |
| 100509-9 | Pediatric hematology-oncology Outpatient Progress note | |
| 10051-1 | S wave duration in lead III | |
| 100510-7 | Pediatric infectious diseases Outpatient Progress note | |
| 100511-5 | Pediatric otolaryngology Outpatient Progress note | |
| 100512-3 | Pediatric pulmonology Outpatient Progress note | |
| 100513-1 | Pediatric rheumatology Outpatient Progress note | |
| 100514-9 | Pediatric surgery Outpatient Progress note | |
| 100515-6 | Pediatric transplant hepatology Outpatient Progress note | |
| 100516-4 | Pediatric urology Outpatient Progress note | |
| 100517-2 | Pharmacogenomics Outpatient Progress note | |
| 100518-0 | Physical medicine and rehab Outpatient Progress note | |
| 100519-8 | Physical therapy Outpatient Progress note | |
| 10052-9 | S wave duration in lead V1 | |
| 100520-6 | Plastic surgery Outpatient Progress note | |
| 100521-4 | Podiatry Outpatient Progress note | |
| 100522-2 | Psychiatry Hospital Progress note | |
| 100523-0 | Psychology Outpatient Progress note | |
| 100524-8 | Pulmonary Outpatient Progress note | |
| 100525-5 | Radiation oncology Outpatient Progress note | |
| 100526-3 | Radiology Outpatient Progress note | |
| 100527-1 | Recreational therapy Outpatient Progress note | |
| 100528-9 | Reproductive endocrinology and infertility Outpatient Progress note | |
| 100529-7 | Research Outpatient Progress note | |
| 10053-7 | S wave duration in lead V2 | |
| 100530-5 | Rheumatology Outpatient Progress note | |
| 100531-3 | Sleep medicine Outpatient Progress note | |
| 100532-1 | Social worker Outpatient Progress note | |
| 100533-9 | Solid Organ Transplant Outpatient Progress note | |
| 100534-7 | Speech-language pathology Outpatient Progress note | |
| 100535-4 | Spinal surgery Outpatient Progress note | |
| 100536-2 | Sports medicine Outpatient Progress note | |
| 100537-0 | Surgery of the hand Outpatient Progress note | |
| 100538-8 | Telehealth+Outpatient Progress note | |
| 100539-6 | Thromboembolism Outpatient Progress note | |
| 10054-5 | S wave duration in lead V3 | |
| 100540-4 | Transplant surgery Outpatient Progress note | |
| 100541-2 | Trauma Outpatient Progress note | |
| 100542-0 | Urology Outpatient Progress note | |
| 100543-8 | Vascular neurology Outpatient Progress note | |
| 100544-6 | Vascular surgery Outpatient Progress note | |
| 100545-3 | Wound care management Outpatient Progress note | |
| 100546-1 | Wound, Ostomy, and Continence Care Outpatient Progress note | |
| 100547-9 | Adolescent medicine Hospital Progress note | |
| 100548-7 | Allergy and Immunology Hospital Progress note | |
| 100549-5 | Allergy Hospital Progress note | |
| 10055-2 | S wave duration in lead V4 | |
| 100550-3 | Attending Hospital Progress note | |
| 100551-1 | Audiology Hospital Progress note | |
| 100552-9 | Bariatric surgery Hospital Progress note | |
| 100553-7 | Blood banking and transfusion medicine Hospital Progress note | |
| 100554-5 | Bone Marrow Transplant Hospital Progress note | |
| 100555-2 | Breastfeeding Hospital Progress note | |
| 100556-0 | Burn management Hospital Progress note | |
| 100557-8 | Cardiac surgery Hospital Progress note | |
| 100558-6 | Cardiopulmonary Hospital Progress note | |
| 100559-4 | Child and adolescent psychiatry Hospital Progress note | |
| 10056-0 | S wave duration in lead V5 | |
| 100560-2 | Clinical cardiac electrophysiology Hospital Progress note | |
| 100561-0 | Clinical genetics Hospital Progress note | |
| 100562-8 | Clinical neurophysiology Hospital Progress note | |
| 100563-6 | Clinical pathology Hospital Progress note | |
| 100564-4 | Colon and rectal surgery Hospital Progress note | |
| 100565-1 | Consultant Hospital Progress note | |
| 100566-9 | Dentistry Hospital Progress note | |
| 100567-7 | Dermatology Hospital Progress note | |
| 100568-5 | Developmental-behavioral pediatrics Hospital Progress note | |
| 100569-3 | Dialysis and Therapeutic apheresis Hospital Progress note | |
| 10057-8 | S wave duration in lead V6 | |
| 100570-1 | Eating disorders Hospital Progress note | |
| 100571-9 | Endocrinology Hospital Progress note | |
| 100572-7 | Family medicine Hospital Progress note | |
| 100573-5 | Gastroenterology Hospital Progress note | |
| 100574-3 | General medicine Hospital Progress note | |
| 100575-0 | Geriatric medicine Hospital Progress note | |
| 100576-8 | Gynecologic oncology Hospital Progress note | |
| 100577-6 | Gynecology Hospital Progress note | |
| 100578-4 | Healthcare navigator Hospital Progress note | |
| 100579-2 | Heart failure Hospital Progress note | |
| 10058-6 | S' wave amplitude in lead AVF | |
| 100580-0 | Heart failure+Transplant cardiology Hospital Progress note | |
| 100581-8 | Hematology Hospital Progress note | |
| 100582-6 | Hematology+Medical oncology Hospital Progress note | |
| 100583-4 | Hepatology Hospital Progress note | |
| 100584-2 | Immunology Hospital Progress note | |
| 100585-9 | Infectious disease Hospital Progress note | |
| 100586-7 | Internal medicine Hospital Progress note | |
| 100587-5 | Interventional cardiology Hospital Progress note | |
| 100588-3 | Interventional radiology Hospital Progress note | |
| 100589-1 | Hospital Mechanical circulatory support Progress note | |
| 10059-4 | S' wave amplitude in lead AVL | |
| 100590-9 | Medical Aid in Dying Hospital Progress note | |
| 100591-7 | Mental health Hospital Progress note | |
| 100592-5 | Multi-specialty program Hospital Progress note | |
| 100593-3 | Neonatal perinatal medicine Hospital Progress note | |
| 100594-1 | Nephrology Hospital Progress note | |
| 100595-8 | Neurological surgery Hospital Progress note | |
| 100596-6 | Neurology Hospital Progress note | |
| 100597-4 | Neurology with special qualifications in child neurology Hospital Progress note | |
| 100598-2 | Nurse practitioner Hospital Progress note | |
| 100599-0 | Nurse Hospital Progress note | |
| 10060-2 | S' wave amplitude in lead AVR | |
| 100600-6 | Nutrition and dietetics Hospital Progress note | |
| 100601-4 | Obstetrics and Gynecology Hospital Progress note | |
| 100602-2 | Obstetrics Hospital Progress note | |
| 100603-0 | Occupational therapy Hospital Progress note | |
| 100604-8 | Oncology Hospital Progress note | |
| 100605-5 | Ophthalmology Hospital Progress note | |
| 100606-3 | Oral and Maxillofacial Surgery Hospital Progress note | |
| 100607-1 | Orthopaedic surgery Hospital Progress note | |
| 100608-9 | Orthotics prosthetics Hospital Progress note | |
| 100609-7 | Otolaryngology Hospital Progress note | |
| 10061-0 | S' wave amplitude in lead I | |
| 100610-5 | Pain medicine Hospital Progress note | |
| 100611-3 | Palliative care Hospital Progress note | |
| 100612-1 | Pastoral care Hospital Progress note | |
| 100613-9 | Pediatric cardiology Hospital Progress note | |
| 100614-7 | Pediatric dermatology Hospital Progress note | |
| 100615-4 | Pediatric endocrinology Hospital Progress note | |
| 100616-2 | Pediatric gastroenterology Hospital Progress note | |
| 100617-0 | Pediatric hematology-oncology Hospital Progress note | |
| 100618-8 | Pediatric infectious diseases Hospital Progress note | |
| 100619-6 | Pediatric otolaryngology Hospital Progress note | |
| 10062-8 | S' wave amplitude in lead II | |
| 100620-4 | Pediatric pulmonology Hospital Progress note | |
| 100621-2 | Pediatric rheumatology Hospital Progress note | |
| 100622-0 | Pediatric surgery Hospital Progress note | |
| 100623-8 | Pediatric transplant hepatology Hospital Progress note | |
| 100624-6 | Pharmacogenomics Hospital Progress note | |
| 100625-3 | Pharmacology Hospital Progress note | |
| 100626-1 | Physical medicine and rehab Hospital Progress note | |
| 100627-9 | Physical therapy Hospital Progress note | |
| 100628-7 | Plastic surgery Hospital Progress note | |
| 100629-5 | Podiatry Hospital Progress note | |
| 10063-6 | S' wave amplitude in lead III | |
| 100630-3 | Psychology Hospital Progress note | |
| 100631-1 | Radiation oncology Hospital Progress note | |
| 100632-9 | Radiology Hospital Progress note | |
| 100633-7 | Rapid response team Hospital Progress note | |
| 100634-5 | Recreational therapy Hospital Progress note | |
| 100635-2 | Reproductive endocrinology and infertility Hospital Progress note | |
| 100636-0 | Research Hospital Progress note | |
| 100637-8 | Rheumatology Hospital Progress note | |
| 100638-6 | Sleep medicine Hospital Progress note | |
| 100639-4 | Social worker Hospital Progress note | |
| 10064-4 | S' wave amplitude in lead V1 | |
| 100640-2 | Solid Organ Transplant Hospital Progress note | |
| 100641-0 | Speech-language pathology Hospital Progress note | |
| 100642-8 | Spinal surgery Hospital Progress note | |
| 100643-6 | Surgery of the hand Hospital Progress note | |
| 100644-4 | Thromboembolism Hospital Progress note | |
| 100645-1 | Trauma Hospital Progress note | |
| 100646-9 | Urology Hospital Progress note | |
| 100647-7 | Vascular neurology Hospital Progress note | |
| 100648-5 | Vascular surgery Hospital Progress note | |
| 100649-3 | Wound care management Hospital Progress note | |
| 10065-1 | S' wave amplitude in lead V2 | |
| 100650-1 | Wound, Ostomy, and Continence Care Hospital Progress note | |
| 100651-9 | Hospital COVID-19 Intubation Progress note | |
| 100652-7 | Pure tone bone conduction threshold audiometry panel | |
| 100653-5 | Pure tone air conduction threshold audiometry panel | |
| 100655-0 | XR Sella turcica Lateral | |
| 100656-8 | Maternal and fetal medicine Outpatient Progress note | |
| 100657-6 | Maternal and fetal medicine Telephone encounter+Hospital Progress note | |
| 100658-4 | Hospital COVID-19 Progress note | |
| 100659-2 | Maternal and fetal medicine Hospital Progress note | |
| 10066-9 | S' wave amplitude in lead V3 | |
| 100660-0 | Maternal and fetal medicine Telephone encounter+Outpatient Progress note | |
| 100661-8 | Psychiatry Outpatient Progress note | |
| 10067-7 | S' wave amplitude in lead V4 | |
| 10068-5 | S' wave amplitude in lead V5 | |
| 10069-3 | S' wave amplitude in lead V6 | |
| 100697-2 | Interventional radiology Outpatient Note | |
| 100698-0 | Social Determinants of Health screening report Document | |
| 10070-1 | S' wave duration in lead AVF | |
| 10071-9 | S' wave duration in lead AVL | |
| 100718-6 | Undersea and hyperbaric medicine Discharge summary | |
| 100719-4 | Surgical oncology Discharge summary | |
| 10072-7 | S' wave duration in lead AVR | |
| 100720-2 | Reproductive endocrinology and infertility Discharge summary | |
| 100721-0 | Community health care Discharge summary | |
| 100722-8 | Integrative medicine Discharge summary | |
| 100723-6 | Sports medicine Discharge summary | |
| 100724-4 | Diabetology Discharge summary | |
| 100725-1 | Optometry Discharge summary | |
| 100726-9 | Podiatry Discharge summary | |
| 100727-7 | Chiropractic medicine Discharge summary | |
| 100728-5 | Cardiac surgery Discharge summary | |
| 100729-3 | Breastfeeding Discharge summary | |
| 10073-5 | S' wave duration in lead I | |
| 100730-1 | Transplant surgery Discharge summary | |
| 100731-9 | Urgent care center Discharge summary | |
| 10074-3 | S' wave duration in lead II | |
| 10075-0 | S' wave duration in lead III | |
| 100752-5 | Exacerbating factors - Reported | |
| 100753-3 | Alleviating factors - Reported | |
| 100758-2 | Estimated lung age by based on clinical data | |
| 100759-0 | Inspiratory reserve [Volume] Respiratory system by Spirometry | |
| 10076-8 | S' wave duration in lead V1 | |
| 100760-8 | XR Radius and Ulna - left Single view | |
| 10077-6 | S' wave duration in lead V2 | |
| 10078-4 | S' wave duration in lead V3 | |
| 10079-2 | S' wave duration in lead V4 | |
| 10080-0 | S' wave duration in lead V5 | |
| 10081-8 | S' wave duration in lead V6 | |
| 10082-6 | ST initial amplitude 6 ms in lead AVF | |
| 100821-8 | National POLST form: portable medical order panel | |
| 100822-6 | Cardiopulmonary resuscitation orders | |
| 100823-4 | Initial portable medical treatment orders | |
| 100824-2 | Additional portable medical orders or instructions | |
| 100825-9 | Medically assisted nutrition orders | |
| 100826-7 | Portable medical order AndOr advance directive review | |
| 100827-5 | Portable medical order discussion participants | |
| 100828-3 | Portable medical order administrative information | |
| 10083-4 | ST initial amplitude 6 ms in lead AVL | |
| 10084-2 | ST initial amplitude 6 ms in lead AVR | |
| 10085-9 | ST initial amplitude 6 ms in lead I | |
| 100852-3 | NM Bones Views for metastasis W Sr-89 IV | |
| 100853-1 | NM Pericardial space Pericardial effusion | |
| 10086-7 | ST initial amplitude 6 ms in lead II | |
| 10087-5 | ST initial amplitude 6 ms in lead III | |
| 100875-4 | Fetal Heart Document limited US | |
| 100876-2 | Fetal Heart Document US | |
| 100877-0 | US Heart Transesophageal during surgery | |
| 100878-8 | Endoscopic ultrasound study Upper GI tract Document | |
| 100879-6 | US Guidance for cryoablation of Breast - right | |
| 10088-3 | ST initial amplitude 6 ms in lead V1 | |
| 100880-4 | US Guidance for cryoablation of Breast - left | |
| 100881-2 | MR Guidance for cryoablation of Bone | |
| 100882-0 | MR Peritoneum W contrast percutaneous intraperitoneal | |
| 100883-8 | MR Guidance for biopsy of Kidney - left | |
| 100884-6 | MR Guidance for biopsy of Kidney - right | |
| 10089-1 | ST initial amplitude 6 ms in lead V2 | |
| 100894-5 | Recommended screening frequency Narrative | |
| 10090-9 | ST initial amplitude 6 ms in lead V3 | | |
| 10091-7 | ST initial amplitude 6 ms in lead V4 | | |
| 10092-5 | ST initial amplitude 6 ms in lead V5 | | |
| 10093-3 | ST initial amplitude 6 ms in lead V6 | | |
| 10094-1 | ST slope in lead AVF | | |
| 10095-8 | ST slope in lead AVL | | |
| 10096-6 | ST slope in lead AVR | | |
| 100966-1 | Oncofertility consultation note | | |
| 100967-9 | Fetal Document Fetal Heart Tracing | | |
| 10097-4 | ST slope in lead I | | |
| 100970-3 | Portable medical order completion information | | |
| 100971-1 | Clinical record panel | | |
| 100975-2 | Induced abortion method | | |
| 10098-2 | ST slope in lead II | | |
| 10099-0 | ST slope in lead III | | |
| 10100-6 | ST slope in lead V1 | | |
| 101000-8 | Health informatics leader and champion of semantic interoperability | | |
| 101001-6 | Chief technical architect and steadfast leader of LOINC | | |
| 101005-7 | Hospitalist Discharge summary | | |
| 101006-5 | Osteopathic medicine Discharge summary | | |
| 101007-3 | Chiropody Discharge summary | | |
| 101008-1 | Medical Aid in Dying History and physical note | | |
| 101009-9 | Integrative medicine History and physical note | | |
| 10101-4 | ST slope in lead V2 | | |
| 101010-7 | Bariatric surgery History and physical note | | |
| 101011-5 | Chiropody History and physical note | | |
| 101012-3 | Chiropractic medicine History and physical note | | |
| 101013-1 | Community health care History and physical note | | |
| 101014-9 | Clinical cardiac electrophysiology History and physical note | | |
| 101015-6 | Surgical oncology History and physical note | | |
| 101016-4 | Undersea and hyperbaric medicine History and physical note | | |
| 101017-2 | Kinesiotherapy History and physical note | | |
| 101018-0 | Hospitalist History and physical note | | |
| 101019-8 | Nuclear medicine History and physical note | | |
| 10102-2 | ST slope in lead V3 | | |
| 101020-6 | Diabetology History and physical note | | |
| 101021-4 | Optometry History and physical note | | |
| 101022-2 | Osteopathic medicine History and physical note | | |
| 101023-0 | Orthotics prosthetics History and physical note | | |
| 101024-8 | Reproductive endocrinology and infertility History and physical note | | |
| 101025-5 | Sports medicine History and physical note | | |
| 101026-3 | Urgent care center History and physical note | | |
| 101027-1 | Child and adolescent psychology History and physical note | | |
| 101028-9 | Cardiac surgery History and physical note | | |
| 101029-7 | Hematology+Medical oncology History and physical note | | |
| 10103-0 | ST slope in lead V4 | | |
| 101030-5 | Neuropsychology History and physical note | | |
| 101031-3 | Chiropody Consult note | | |
| 101032-1 | Physician assistant Consult note | | |
| 101033-9 | Chiropody Procedure note | | |
| 101034-7 | Chiropractic medicine procedure note | | |
| 101035-4 | Osteopathic medicine Procedure note | | |
| 101036-2 | Integrative medicine Progress note | | |
| 101037-0 | Chiropody Progress note | | |
| 101038-8 | Aerospace medicine Consult note | | |
| 101039-6 | Aerospace medicine Progress note | | |
| 10104-8 | ST slope in lead V5 | | |
| 101040-4 | Integrative medicine Procedure note | | |
| 101041-2 | Aerospace medicine procedure note | | |
| 101042-0 | Urgent care center Progress note | | |
| 101043-8 | Urgent care center Consult note | | |
| 101044-6 | Bariatric surgery procedure note | | |
| 101045-3 | Hospitalist Procedure note | | |
| 101046-1 | Hospitalist Progress note | | |
| 101047-9 | Undersea and hyperbaric medicine Consult note | | |
| 101048-7 | Hospitalist Consult note | | |
| 101049-5 | Anesthesiology Surgical operation note | | |
| 10105-5 | ST slope in lead V6 | | |
| 101050-3 | Bariatric surgery Surgical operation note | | |
| 101051-1 | Reproductive endocrinology and infertility Surgical operation note | | |
| 101052-9 | Osteopathic medicine Consult note | | |
| 101053-7 | Obstetrics Midwife Evaluation note | | |
| 101054-5 | Chiropody Outpatient Note | | |
| 101055-2 | Critical care medicine.team Conference note | | |
| 101056-0 | Rapid response team Conference note | | |
| 101057-8 | Psychiatry Telehealth Admission evaluation note | | |
| 101058-6 | Geriatric medicine Team Conference note | | |
| 101059-4 | Geriatric medicine Letter | | |
| 10106-3 | ST wave end displacement in lead AVF | | |
| 10107-1 | ST wave end displacement in lead AVL | | |
| 10108-9 | ST wave end displacement in lead AVR | | |
| 10109-7 | ST wave end displacement in lead I | | |
| 10110-5 | ST wave end displacement in lead II | | |
| 10111-3 | ST wave end displacement in lead III | | |
| 101114-7 | NCSBN ID | | |
| 10112-1 | ST wave end displacement in lead V1 | | |
| 101129-5 | Laboratory device Assay Sensitivity | | |
| 10113-9 | ST wave end displacement in lead V2 | | |
| 101133-7 | Organ AndOr tissue donation consent Document | | |
| 101134-5 | Appointment reminder | | |
| 101135-2 | Ambulance Discharge summary | | |
| 101136-0 | Radiation oncology End of treatment letter | | |
| 10114-7 | ST wave end displacement in lead V3 | | |
| 10115-4 | ST wave end displacement in lead V4 | | |
| 101150-1 | Right ventricular Cardiac output by Fick method | | |
| 101151-9 | Right ventricular Cardiac output by Indicator dilution | | |
| 10116-2 | ST wave end displacement in lead V5 | | |
| 10117-0 | ST wave end displacement in lead V6 | | |
| 10118-8 | ST wave mid displacement in lead AVF | | |
| 10119-6 | ST wave mid displacement in lead AVL | | |
| 10120-4 | ST wave mid displacement in lead AVR | | |
| 10121-2 | ST wave mid displacement in lead I | | |
| 10122-0 | ST wave mid displacement in lead II | | |
| 10123-8 | ST wave mid displacement in lead III | | |
| 10124-6 | ST wave mid displacement in lead V1 | | |
| 10125-3 | ST wave mid displacement in lead V2 | | |
| 10126-1 | ST wave mid displacement in lead V3 | | |
| 10127-9 | ST wave mid displacement in lead V4 | | |
| 10128-7 | ST wave mid displacement in lead V5 | | |
| 10129-5 | ST wave mid displacement in lead V6 | | |
| 10130-3 | T' wave amplitude in lead AVF | | |
| 101301-0 | XR Thoracic spine Views 2 and Abdomen AP and Lateral | | |
| 10131-1 | T' wave amplitude in lead AVL | | |
| 10132-9 | T' wave amplitude in lead AVR | | |
| 10133-7 | T' wave amplitude in lead I | | |
| 10134-5 | T' wave amplitude in lead II | | |
| 101349-9 | Jurisdiction where advance directive is accepted [Location] | | |
| 10135-2 | T' wave amplitude in lead III | | |
| 101350-7 | Orthopaedic and Trauma Surgery Consult note | | |
| 10136-0 | T' wave amplitude in lead V1 | | |
| 10137-8 | T' wave amplitude in lead V2 | | |
| 10138-6 | T' wave amplitude in lead V3 | | |
| 10139-4 | T' wave amplitude in lead V4 | | |
| 10140-2 | T' wave amplitude in lead V5 | | |
| 10141-0 | T' wave amplitude in lead V6 | | |
| 10142-8 | T wave amplitude in lead AVF | | |
| 10143-6 | T wave amplitude in lead AVL | | |
| 101437-2 | FDA product label Intentional animal genomic alteration label | | |
| 101438-0 | CHAMPS pediatric fall risk assessment | | |
| 101439-8 | Change in mental status | | |
| 10144-4 | T wave amplitude in lead AVR | | |
| 101440-6 | History of Falls | | |
| 101441-4 | CHAMPS pediatric fall risk assessment [Interpretation] | | |
| 101442-2 | Total score CHAMPS pediatric fall risk assessment | | |
| 10145-1 | T wave amplitude in lead I | | |
| 10146-9 | T wave amplitude in lead II | | |
| 101468-7 | Risk adjustment coding gap report Document | | |
| 10147-7 | T wave amplitude in lead III | | |
| 10148-5 | T wave amplitude in lead V1 | | |
| 10149-3 | T wave amplitude in lead V2 | | |
| 10150-1 | T wave amplitude in lead V3 | | |
| 101507-2 | Suicide screening report | | |
| 10151-9 | T wave amplitude in lead V4 | | |
| 10152-7 | T wave amplitude in lead V5 | | |
| 10153-5 | T wave amplitude in lead V6 | | |
| 10154-3 | Chief complaint Narrative - Reported | | |
| 101541-1 | Multidisciplinary Comprehensive plan of care note | | |
| 101549-4 | Schmid fall risk assessment | | |
| 10155-0 | History of allergies, reported | | |
| 101550-2 | Total score Schmid fall risk assessment | | |
| 101551-0 | Schmid fall risk assessment [Interpretation] | | |
| 10156-8 | History of Childhood diseases Narrative | | |
| 10157-6 | History of family member diseases Narrative | | |
| 101572-6 | Prenatal visits for this pregnancy | | |
| 101573-4 | Diet at discharge | | |
| 101574-2 | Body temperature 1 hour --at admission | | |
| 101575-9 | Delayed cord clamping Newborn | | |
| 101577-5 | Cardioversion report Heart Document | | |
| 101578-3 | Cardiac device monitoring report | | |
| 101579-1 | Heart Multisection transthoracic limited by US | | |
| 10158-4 | History of Functional status Narrative | | |
| 101580-9 | US Heart Transthoracic limited for congenital disease | | |
| 101581-7 | US Heart Transthoracic for congenital disease | | |
| 101582-5 | NM Gastrointestinal tract Views for protein-losing enteropathy W Tc-99m HSA IV | | |
| 10159-2 | History of Industrial exposure Narrative | | |
| 10160-0 | History of Medication use Narrative | | |
| 10161-8 | History of Occupational exposure Narrative | | |
| 10162-6 | History of pregnancies Narrative | | |
| 10163-4 | History of pregnancies | | |
| 10164-2 | History of Present illness Narrative | | |
| 10165-9 | Deprecated History of psychiatric symptoms and diseases Narrative | | |
| 10166-7 | History of Social function Narrative | | |
| 10167-5 | History of Surgical procedures Narrative | | |
| 10168-3 | History of Cardiovascular system disorders Narrative | | |
| 10169-1 | History of Ear disorders Narrative | | |
| 10170-9 | History of Endocrine system disorders Narrative | | |
| 10171-7 | History of Eyes disorders Narrative | | |
| 10172-5 | History of Hematologic system disorders Narrative | | |
| 10173-3 | History of Musculoskeletal system disorders Narrative | | |
| 10174-1 | History of Nose disorders Narrative | | |
| 10175-8 | History of Oral cavity disorders Narrative | | |
| 10176-6 | History of Reproductive system disorders Narrative | | |
| 10177-4 | History of Respiratory system disorders Narrative | | |
| 10178-2 | History of Skin disorders Narrative | | |
| 10179-0 | History of Throat and Neck disorders Narrative | | |
| 10180-8 | History of Throat and Neck disorders | | |
| 10181-6 | History of Urinary tract disorders Narrative | | |
| 10182-4 | History of Travel Narrative | | |
| 10183-2 | Hospital discharge medications Narrative | | |
| 10184-0 | Hospital discharge physical findings Narrative | | |
| 10185-7 | Hospital discharge procedures Narrative | | |
| 10186-5 | Identifying information Narrative Observed | | |
| 10187-3 | Review of systems Narrative - Reported | | |
| 10188-1 | Review of systems overview Narrative - Reported | | |
| 10189-9 | Review of systems overview - Reported | | |
| 10190-7 | Mental status Narrative | | |
| 10191-5 | Physical findings of Abdomen Narrative | | |
| 10192-3 | Physical findings of Back Narrative | | |
| 10193-1 | Physical findings of Breasts Narrative | | |
| 10194-9 | Physical findings of Neurologic deep tendon reflexes Narrative | | |
| 10195-6 | Physical findings of Ear Narrative | | |
| 10196-4 | Physical findings of Extremities Narrative | | |
| 10197-2 | Physical findings of Eye Narrative | | |
| 10198-0 | Physical findings of Genitourinary tract Narrative | | |
| 10199-8 | Physical findings of Head Narrative | | |
| 10200-4 | Physical findings of Heart Narrative | | |
| 10201-2 | Physical findings of Mouth and Throat and Teeth Narrative | | |
| 10202-0 | Physical findings of Nervous system Narrative | | |
| 10203-8 | Physical findings of Nose Narrative | | |
| 10204-6 | Physical findings of Pelvis Narrative | | |
| 10205-3 | Physical findings of Rectum Narrative | | |
| 10206-1 | Physical findings of Skin Narrative | | |
| 10207-9 | Physical findings of Thorax and Lungs Narrative | | |
| 10208-7 | Physical findings of Vessels Narrative | | |
| 10209-5 | Physical findings of Neurologic balance and Coordination Narrative | | |
| 10210-3 | Physical findings of General status Narrative | | |
| 10211-1 | Physical findings of Sense of touch Narrative | | |
| 10212-9 | Physical findings of Strength Narrative | | |
| 10213-7 | Surgical operation note anesthesia Narrative | | |
| 10214-5 | Surgical operation note anesthesia duration | | |
| 10215-2 | Surgical operation note findings Narrative | | |
| 10216-0 | Surgical operation note fluids Narrative | | |
| 10217-8 | Surgical operation note indications [Interpretation] Narrative | | |
| 10218-6 | Surgical operation note postoperative diagnosis Narrative | | |
| 10219-4 | Surgical operation note preoperative diagnosis Narrative | | |
| 10220-2 | Surgical operation note prep time duration | | |
| 10221-0 | Surgical operation note specimens taken Narrative | | |
| 10222-8 | Surgical operation note surgical complications [Interpretation] Narrative | | |
| 10223-6 | Surgical operation note surgical procedure Narrative | | |
| 10224-4 | Hemodynamic method special circumstances | | |
| 10225-1 | Cardiac measurement device Institution inventory number | | |
| 10227-7 | Cardiac measurement device Vendor model number | | |
| 10228-5 | Cardiac measurement device Vendor serial number | | |
| 10229-3 | Hemodynamic method Type of | | |
| 10230-1 | Left ventricular Ejection fraction | | |
| 10231-9 | Right ventricular Ejection fraction | | |
| 10249-1 | Heart rate device Institution inventory number | | |
| 10250-9 | Heart rate device Vendor model number | | |
| 10251-7 | Heart rate device Vendor serial number | | |
| 10252-5 | Biliary drain site | | |
| 10253-3 | Type of Biliary drain | | |
| 10254-1 | Type of Peritoneal drain | | |
| 10255-8 | Type of Subarachnoid drain | | |
| 10256-6 | Biliary drain Institution inventory number | | |
| 10257-4 | Chest tube Institution inventory number | | |
| 10258-2 | Enteral tube Institution inventory number | | |
| 10259-0 | Gastrostomy tube Institution inventory number | | |
| 10260-8 | GI tube Institution inventory number | | |
| 10261-6 | Intravascular tube Institution inventory number | | |
| 10262-4 | IO tube Institution inventory number | | |
| 10263-2 | Nasogastric tube Institution inventory number | | |
| 10264-0 | Oral tube Institution inventory number | | |
| 10265-7 | Peritoneal drain Institution inventory number | | |
| 10266-5 | Peritoneal tube Institution inventory number | | |
| 10267-3 | Rate control device Institution inventory number | | |
| 10268-1 | Stool collection device Institution inventory number | | |
| 10269-9 | Subarachnoid drain Institution inventory number | | |
| 10270-7 | Synovial drain Institution inventory number | | |
| 10271-5 | Tube or drain Institution inventory number | | |
| 10272-3 | Upper GI tube Institution inventory number | | |
| 10273-1 | Bladder irrigation tube Institution inventory number | | |
| 10274-9 | Urine tube Institution inventory number | | |
| 10275-6 | Wound drain device Institution inventory number | | |
| 10276-4 | Peritoneal drain site | | |
| 10277-2 | Stool collection site | | |
| 10278-0 | Subarachnoid drain site | | |
| 10279-8 | Biliary drain Vendor model number | | |
| 10280-6 | Chest tube Vendor model number | | |
| 10281-4 | Enteral tube Vendor model number | | |
| 10282-2 | Gastrostomy tube Vendor model number | | |
| 10283-0 | GI tube Vendor model number | | |
| 10284-8 | Intravascular tube Vendor model number | | |
| 10285-5 | IO tube Vendor model number | | |
| 10286-3 | Nasogastric tube Vendor model number | | |
| 10287-1 | Oral tube Vendor model number | | |
| 10288-9 | Peritoneal drain Vendor model number | | |
| 10289-7 | Peritoneal tube Vendor model number | | |
| 10290-5 | Rate control device Vendor model number | | |
| 10291-3 | Stool collection device Vendor model number | | |
| 10292-1 | Subarachnoid drain Vendor model number | | |
| 10293-9 | Synovial drain Vendor model number | | |
| 10294-7 | Tube or drain Vendor model number | | |
| 10295-4 | Upper GI tube Vendor model number | | |
| 10296-2 | Bladder irrigation tube Vendor model number | | |
| 10297-0 | Urine tube Vendor model number | | |
| 10298-8 | Wound drain device Vendor model number | | |
| 10299-6 | Biliary drain Vendor serial number | | |
| 10300-2 | Chest tube Vendor serial number | | |
| 10301-0 | Enteral tube Vendor serial number | | |
| 10302-8 | Gastrostomy tube Vendor serial number | | |
| 10303-6 | GI tube Vendor serial number | | |
| 10304-4 | Intravascular tube Vendor serial number | | |
| 10305-1 | IO tube Vendor serial number | | |
| 10306-9 | Nasogastric tube Vendor serial number | | |
| 10307-7 | Oral tube Vendor serial number | | |
| 10308-5 | Peritoneal drain Vendor serial number | | |
| 10309-3 | Peritoneal tube Vendor serial number | | |
| 10310-1 | Rate control device Vendor serial number | | |
| 10311-9 | Stool collection device Vendor serial number | | |
| 10312-7 | Subarachnoid drain Vendor serial number | | |
| 10313-5 | Synovial drain Vendor serial number | | |
| 10314-3 | Tube or drain Vendor serial number | | |
| 10315-0 | Upper GI tube Vendor serial number | | |
| 10316-8 | Bladder irrigation tube Vendor serial number | | |
| 10317-6 | Urine tube Vendor serial number | | |
| 10318-4 | Wound drain device Vendor serial number | | |
| 10319-2 | Enema device Institution inventory number | | |
| 10320-0 | Enema device Vendor model number | | |
| 10321-8 | Enema device Vendor serial number | | |
| 10322-6 | Potassium intake 24 hour | | |
| 10323-4 | Wound drain fluid [Appearance] Lower GI tract | | |
| 10324-2 | Breath rate device Institution inventory number | | |
| 10325-9 | Breath rate device Vendor model number | | |
| 10326-7 | Breath rate device Vendor serial number | | |
| 10830-8 | Deprecated Surgical operation note complications | | |
| 10831-6 | Surgical operation note complications [Interpretation] | | |
| 11283-9 | Acuity assessment [Function] at First encounter | | |
| 11284-7 | Acuity assessment practitioner identification | | |
| 11285-4 | Acuity assessment practitioner profession | | |
| 11286-2 | Alcohol binge episodes per month - Reported | | |
| 11287-0 | Alcoholic drinks per drinking day - Reported | | |
| 11288-8 | Arrival time documented | | |
| 11289-6 | Body temperature at First encounter | | |
| 11290-4 | Body temperature measurement site at First encounter | | |
| 11291-2 | Respiratory rate at First encounter | | |
| 11292-0 | Deprecated Chief complaint: Prid: Pt: ^Patient: Nom: Reported | | |
| 11293-8 | Type of Referral source | | |
| 11294-6 | Current employment Narrative - Reported | | |
| 11295-3 | Current employment - Reported | | |
| 11296-1 | ED clinical finding practitioner identifier | | |
| 11297-9 | ED clinical finding practitioner profession | | |
| 11298-7 | ED consultant practitioner identifier | | |
| 11299-5 | ED consultant practitioner profession | | |
| 11300-1 | ED diagnosis | | |
| 11301-9 | ED diagnosis type | | |
| 11302-7 | ED discharge disposition | | |
| 11303-5 | ED disposition consult/referral | | |
| 11304-3 | ED disposition diagnosis practitioner identification | | |
| 11305-0 | ED disposition diagnosis practitioner profession | | |
| 11306-8 | ED medication practitioner identification | | |
| 11307-6 | ED medication practitioner profession | | |
| 11308-4 | ED outcome observation practitioner identification | | |
| 11309-2 | ED outcome observation practitioner profession | | |
| 11310-0 | ED patient satisfaction report type | | |
| 11311-8 | ED procedure practitioner profession | | |
| 11312-6 | ED procedure practitioner identifier | | |
| 11313-4 | ED procedure result observation [Interpretation] | | |
| 11314-2 | ED procedure result type | | |
| 11315-9 | ED service level | | |
| 11316-7 | ED service level practitioner profession | | |
| 11317-5 | ED service level practitioner identification | | |
| 11318-3 | Ambulance transport agency EMS system | | |
| 11319-1 | Ambulance transport unit [Identifier] EMS system | | |
| 11320-9 | Feeding and dietary status Narrative - Reported | | |
| 11321-7 | Feeding and dietary status - Reported | | |
| 11322-5 | History of General health Narrative | | |
| 11323-3 | General health - Reported | | |
| 11324-1 | Glasgow coma score eye opening at First encounter | | |
| 11325-8 | Glasgow coma score motor at First encounter | | |
| 11326-6 | Glasgow coma score verbal at First encounter | | |
| 11327-4 | Heart rate method at First encounter | | |
| 11328-2 | Heart rate at First encounter | | |
| 11329-0 | History general Narrative - Reported | | |
| 11330-8 | History of Alcohol use Narrative | | |
| 11331-6 | History of Alcohol use | | |
| 11332-4 | History of Cognitive function Narrative | | |
| 11333-2 | History of Cognitive function | | |
| 11334-0 | History of Growth+Development Narrative | | |
| 11335-7 | History of Growth+Development | | |
| 11336-5 | History of Hospitalization Narrative | | |
| 11337-3 | History of Hospitalization | | |
| 11338-1 | History of Major illnesses and injuries Narrative | | |
| 11339-9 | History of Major illnesses and injuries | | |
| 11340-7 | History of Occupation Narrative | | |
| 11341-5 | History of Occupation | | |
| 11342-3 | History of Other nonmedical drug use Narrative | | |
| 11343-1 | History of Other nonmedical drug use | | |
| 11344-9 | History of Other social factors Narrative | | |
| 11345-6 | History of Other social factors | | |
| 11346-4 | History of Outpatient visits Narrative | | |
| 11347-2 | History of Outpatient visits | | |
| 11348-0 | History of Past illness Narrative | | |
| 11349-8 | History of Past illness | | |
| 11350-6 | History of Sexual behavior Narrative | | |
| 11351-4 | History of Sexual behavior | | |
| 11352-2 | History of Allergenic and Immunologic disorders Narrative | | |
| 11353-0 | History of Breasts disorders Narrative | | |
| 11354-8 | History of Ears and Nose and Sinuses and Mouth and Throat disorders Narrative | | |
| 11355-5 | History of Gastrointestinal system disorders Narrative | | |
| 11356-3 | History of Genitourinary systems disorders Narrative | | |
| 11357-1 | History of Integumentary system disorders Narrative | | |
| 11358-9 | History of Psychiatric disorders Narrative | | |
| 11359-7 | History of Allergenic and Immunologic disorders | | |
| 11360-5 | History of Breasts disorders | | |
| 11361-3 | History of Ears and Nose and Sinuses and Mouth and Throat disorders | | |
| 11362-1 | History of Gastrointestinal system disorders | | |
| 11363-9 | History of Genitourinary systems disorders | | |
| 11364-7 | History of Integumentary system disorders | | |
| 11365-4 | History of Psychiatric disorders | | |
| 11366-2 | History of Tobacco use Narrative | | |
| 11367-0 | History of Tobacco use | | |
| 11368-8 | Illness or injury onset date and time | | |
| 11369-6 | History of Immunization Narrative | | |
| 11370-4 | Immunization status - Reported | | |
| 11371-2 | Initial visit for chief complaint | | |
| 11372-0 | Injury associated activity | | |
| 11373-8 | Injury cause | | |
| 11374-6 | Injury incident description Narrative | | |
| 11375-3 | Injury intent | | |
| 11376-1 | Injury location | | |
| 11377-9 | Diastolic blood pressure at First encounter | | |
| 11378-7 | Systolic blood pressure at First encounter | | |
| 11379-5 | Deprecated Highest level of education [Time] - Reported | | |
| 11380-3 | Marital status and living arrangements Narrative - Reported | | |
| 11381-1 | Marital status and living arrangements - Reported | | |
| 11382-9 | Medication allergy - Reported | | |
| 11383-7 | Patient problem outcome Narrative | | |
| 11384-5 | Physical examination by organ systems | | |
| 11385-2 | Physical findings of Ankle Narrative | | |
| 11386-0 | Physical findings of Upper arm Narrative | | |
| 11387-8 | Physical findings of Axilla Narrative | | |
| 11388-6 | Physical findings of Buttocks Narrative | | |
| 11389-4 | Physical findings of Calf Narrative | | |
| 11390-2 | Physical findings of Cardiovascular system Narrative | | |
| 11391-0 | Physical findings of Chest Narrative | | |
| 11392-8 | Physical findings of Chest wall Narrative | | |
| 11393-6 | Physical findings of Ears and Nose and Mouth and Throat Narrative | | |
| 11394-4 | Physical findings of Elbow Narrative | | |
| 11395-1 | Deprecated Physical findings: Find: Pt: Extremities: Nar: Observed | | |
| 11396-9 | Deprecated Physical findings: Find: Pt: Extremities: Nar: Observed | | |
| 11397-7 | Physical findings of Foot Narrative | | |
| 11398-5 | Physical findings of Forearm Narrative | | |
| 11399-3 | Physical findings of Gastrointestinal system Narrative | | |
| 11400-9 | Physical findings of Genitalia Narrative | | |
| 11401-7 | Physical findings of Female genitalia Narrative | | |
| 11402-5 | Physical findings of Male genitalia Narrative | | |
| 11403-3 | Physical findings of Groin Narrative | | |
| 11404-1 | Physical findings of Hand Narrative | | |
| 11405-8 | Deprecated Physical findings: Find: Pt: Heart: Nar: Observed | | |
| 11406-6 | Physical findings of Hip Narrative | | |
| 11407-4 | Physical findings of Knee Narrative | | |
| 11408-2 | Deprecated Physical findings: Find: Pt: Mouth & Throat & Teeth: Nar: Observed | | |
| 11409-0 | Deprecated Physical findings: Find: Pt: Mouth & Throat & Teeth: Nar: Observed | | |
| 11410-8 | Physical findings of Musculoskeletal system Narrative | | |
| 11411-6 | Physical findings of Neck Narrative | | |
| 11412-4 | Physical findings of Respiratory system Narrative | | |
| 11413-2 | Physical findings of Shoulder Narrative | | |
| 11414-0 | Physical findings of Thigh Narrative | | |
| 11415-7 | Physical findings of Wrist Narrative | | |
| 11416-5 | Physical findings of Ankle | | |
| 11417-3 | Physical findings of Upper arm | | |
| 11418-1 | Physical findings of Axilla | | |
| 11419-9 | Physical findings of Buttocks | | |
| 11420-7 | Physical findings of Calf | | |
| 11421-5 | Physical findings of Cardiovascular system | | |
| 11422-3 | Physical findings of Chest | | |
| 11423-1 | Physical findings of Chest wall | | |
| 11424-9 | Physical findings of Ears and Nose and Mouth and Throat | | |
| 11425-6 | Physical findings of Elbow | | |
| 11426-4 | Deprecated Physical findings: Find: Pt: Extremities: Nom: Observed | | |
| 11427-2 | Deprecated Physical findings: Find: Pt: Extremities: Nom: Observed | | |
| 11428-0 | Physical findings of Foot | | |
| 11429-8 | Physical findings of Forearm | | |
| 11430-6 | Physical findings of Gastrointestinal system | | |
| 11431-4 | Physical findings of Genitalia | | |
| 11432-2 | Physical findings of Female genitalia | | |
| 11433-0 | Physical findings of Male genitalia | | |
| 11434-8 | Physical findings of Groin | | |
| 11435-5 | Physical findings of Hand | | |
| 11436-3 | Deprecated Physical findings: Find: Pt: Heart: Nom: Observed | | |
| 11437-1 | Physical findings of Hip | | |
| 11438-9 | Physical findings of Knee | | |
| 11439-7 | Deprecated Physical findings: Find: Pt: Mouth & Throat & Teeth: Nom: Observed | | |
| 11440-5 | Deprecated Physical findings: Find: Pt: Mouth & Throat & Teeth: Nom: Observed | | |
| 11441-3 | Physical findings of Musculoskeletal system | | |
| 11442-1 | Physical findings of Neck | | |
| 11443-9 | Physical findings of Respiratory system | | |
| 11444-7 | Physical findings of Shoulder | | |
| 11445-4 | Physical findings of Thigh | | |
| 11446-2 | Physical findings of Wrist | | |
| 11447-0 | Physical findings of Hematologic and Lymphatic and Immunologic System Narrative | | |
| 11448-8 | Physical findings of Hematologic and Lymphatic and Immunologic System | | |
| 11449-6 | Pregnancy status - Reported | | |
| 11450-4 | Problem list - Reported | | |
| 11451-2 | Psychiatric findings Narrative | | |
| 11452-0 | Psychiatric findings | | |
| 11453-8 | Receiving facility EMS system | | |
| 11454-6 | Responsiveness assessment at First encounter | | |
| 11455-3 | Deprecated Review of symptoms and diseases: Find: Pt: ^Patient: Nar: Reported | | |
| 11456-1 | Deprecated Review of symptoms and diseases: Find: Pt: ^Patient: Nom: Reported | | |
| 11457-9 | Safety equipment used | | |
| 11458-7 | Clostridium tetani immunization status | | |
| 11459-5 | Transport mode EMS system | | |
| 11485-0 | Anesthesia records | | |
| 11486-8 | Chemotherapy records | | |
| 11488-4 | Consult note | | |
| 11490-0 | Physician Discharge summary | | |
| 11491-6 | Deprecated Provider-unspecified ED visit note | | |
| 11492-6 | Provider-unspecifed, History and physical note | | |
| 11493-4 | Hospital discharge studies summary Narrative | | |
| 11494-2 | Deprecated Physician Initial assessment note at First encounter | | |
| 11495-9 | Deprecated Physical therapy Initial assessment note at First encounter | | |
| 11496-7 | Deprecated Podiatry Initial assessment note at First encounter | | |
| 11497-5 | Deprecated Psychology Initial assessment note at First encounter | | |
| 11498-3 | Deprecated Social work Initial assessment note at First encounter | | |
| 11499-1 | Deprecated Speech therapy Initial assessment note at First encounter | | |
| 11500-6 | Deprecated Occupational therapy Initial assessment note at First encounter | | |
| 11501-6 | Deprecated Labor and delivery records | | |
| 11502-2 | Laboratory report | | |
| 11503-0 | Medical records | | |
| 11504-8 | Surgical operation note | | |
| 11505-5 | Physician procedure note | | |
| 11506-3 | Progress note | | |
| 11507-1 | Occupational therapy Progress note | | |
| 11508-9 | Physical therapy Progress note | | |
| 11509-7 | Podiatry Progress note | | |
| 11510-5 | Psychology Progress note | | |
| 11511-3 | Deprecated Provider-unspecified progress note | | |
| 11512-1 | Speech-language pathology Progress note | | |
| 11513-9 | Provider.signing [Identifier] Report | | |
| 11514-7 | Chiropractic Episode of care medical records | | |
| 11515-4 | Physical therapy Episode of care medical records | | |
| 11516-2 | Physician Episode of care medical records | | |
| 11517-0 | Podiatry Episode of care medical records | | |
| 11518-8 | Psychology Episode of care medical records | | |
| 11519-6 | Social service Episode of care medical records | | |
| 11520-4 | Speech therapy Episode of care medical records | | |
| 11521-2 | Occupational therapy Episode of care medical records | | |
| 11523-8 | EEG study | | |
| 11524-6 | EKG study | | |
| 11525-3 | US for pregnancy | | |
| 11527-9 | Psychiatry study | | |
| 11530-3 | Surgeon.assisting [Identifier] | | |
| 11531-1 | Surgeon.resident [Identifier] | | |
| 11532-9 | Surgeon.staff [Identifier] | | |
| 11533-7 | Surgical drains | | |
| 11534-5 | Temperature charts | | |
| 11535-2 | Hospital discharge Dx Narrative | | |
| 11537-8 | Surgical drains Narrative | | |
| 11543-6 | Nursery records | | |
| 11544-4 | Hospital discharge follow-up Narrative | | |
| 11612-9 | [#] Abortions | | |
| 11613-7 | [#] Abortions.induced | | |
| 11614-5 | [#] Abortions.spontaneous | | |
| 11615-2 | Fetal Heart Activity US | | |
| 11616-0 | Fetal Heart Narrative Activity US | | |
| 11617-8 | Fetal Limbs Activity US | | |
| 11618-6 | Fetal Limbs Narrative Activity US | | |
| 11619-4 | Fetal Respiratory Activity US | | |
| 11620-2 | Fetal Respiratory Narrative Activity US | | |
| 11621-0 | Fetal Trunk Activity US | | |
| 11622-8 | Fetal Trunk Narrative Activity US | | |
| 11623-6 | Fetal Quadrant four Amniotic fluid index derived by US | | |
| 11624-4 | Fetal Quadrant four one Amniotic fluid index derived by US | | |
| 11625-1 | Fetal Quadrant three Amniotic fluid index derived by US | | |
| 11626-9 | Fetal Quadrant two Amniotic fluid index derived by US | | |
| 11627-7 | Fetal Amniotic fluid index.sum derived by US | | |
| 11628-5 | Fetal Head Binocular distance estimated from Biparietal diameter on US | | |
| 11629-3 | Fetal Head Binocular distance US | | |
| 11630-1 | Fetal Biophysical profile.amniotic fluid volume US | | |
| 11631-9 | Fetal Biophysical profile.body movement US | | |
| 11632-7 | Fetal Biophysical profile.breathing movement US | | |
| 11633-5 | Fetal Heart rate reactivity US | | |
| 11634-3 | Fetal Biophysical profile.sum Derived | | |
| 11635-0 | Fetal Biophysical profile.tone US | | |
| 11636-8 | [#] Births.live | | |
| 11637-6 | [#] Births.preterm | | |
| 11638-4 | [#] Births.still living | | |
| 11639-2 | [#] Births.term | | |
| 1-8 | | Acyclovir [Susceptibility] | |
| 10-9 | | Amdinocillin [Susceptibility] by Serum bactericidal titer | |
| 100-8 | | Cefoperazone [Susceptibility] by Minimum inhibitory concentration (MIC) | |
| 1000-9 | | DBG Ab [Presence] in Serum or Plasma from Blood product unit | |
| 100002-5 | | Specimen care is maintained | |
| 100003-3 | | Team communication is maintained throughout care | |
| 100004-1 | | Demonstrates knowledge of the expected psychosocial responses to the procedure | |
| 100005-8 | | Demonstrates knowledge of nutritional management related to the procedure | |
| 100006-6 | | Demonstrates knowledge of medication management | |
| 100007-4 | | Demonstrates knowledge of pain management | |
| 100008-2 | | Demonstrates knowledge of wound management | |
| 100009-0 | | Demonstrates knowledge of the procedure and expected results | |
| 100010-8 | | No injury related to procedure equipment, medical supplies, or instrumentation | |
| 100011-6 | | No injury related to an electrical source | |
| 100012-4 | | Participates in decisions affecting the patient's plan of care | |
| 100013-2 | | Participates in the discharge process | |
| 100014-0 | | Psychosocial health is maintained at or improved from baseline | |
| 100015-7 | | No injury related to positioning due to care or procedure | |
| 100016-5 | | No injury related to a laser source | |
| 100017-3 | | Perioperative nursing data set outcomes panel [PNDS] | |
| 100019-9 | | ALK gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
| 100020-7 | | GNA11 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
| 100021-5 | | GNAQ gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
| 100022-3 | | IDH1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
| 100023-1 | | IDH2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
| 100024-9 | | SETBP1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
| 100025-6 | | SRSF2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
| 100026-4 | | MET gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
| 100027-2 | | SMAD4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
| 100028-0 | | FBXW7 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
| 100029-8 | | Cancer related multigene analysis in Plasma cell-free DNA by Molecular genetics method | |
| 100030-6 | | Axis I: Temporal aspects score [Mainz Pain Staging System] | |
| 100031-4 | | Axis II: Spatial aspects score [Mainz Pain Staging System] | |
| 100032-2 | | Axis III: Drug taking behavior score [Mainz Pain Staging System] | |
| 100033-0 | | Axis IV: Utilization of the health care system score [Mainz Pain Staging System] | |
| 100041-3 | | Aminoglycoside [Susceptibility] | |
| 100042-1 | | Atovaquone [Susceptibility] | |
| 100043-9 | | Azithromycin+Ethambutol [Susceptibility] | |
| 100044-7 | | Cefcapene [Susceptibility] | |
| 100045-4 | | Cefozopran [Susceptibility] | |
| 100046-2 | | Cefquinome [Susceptibility] | |
| 100047-0 | | Cefteram [Susceptibility] | |
| 100048-8 | | Clarithromycin+Ethambutol [Susceptibility] | |
| 100049-6 | | Eravacycline [Susceptibility] | |
| 100050-4 | | Erythromycin+Ethambutol [Susceptibility] | |
| 100051-2 | | Ethambutol+rifAMPin [Susceptibility] | |
| 100052-0 | | Flomoxef [Susceptibility] | |
| 100053-8 | | Fluoroquinolone [Susceptibility] | |
| 100054-6 | | Gamithromycin [Susceptibility] | |
| 100055-3 | | Optochin [Susceptibility] | |
| 100056-1 | | Panipenem [Susceptibility] | |
| 100057-9 | | Prothionamide [Susceptibility] | |
| 100058-7 | | Prulifloxacin [Susceptibility] | |
| 100059-5 | | Rifapentine [Susceptibility] | |
| 100060-3 | | Tildipirosin [Susceptibility] | |
| 100061-1 | | Tosufloxacin [Susceptibility] | |
| 100087-6 | | Toxocara canis 24-35kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100088-4 | | Taenia solium larva Ab bands panel - Serum by Immunoblot | |
| 100089-2 | | Taenia solium larva 6-8kD Ab [Presence] in Serum by Immunoblot | |
| 100090-0 | | Taenia solium larva 45kD Ab [Presence] in Serum by Immunoblot | |
| 100091-8 | | Trypanosoma cruzi Ab [Units/volume] in Serum by Immunoassay | |
| 100092-6 | | Trypanosoma cruzi Ab bands panel - Serum by Immunoblot | |
| 100093-4 | | Trypanosoma cruzi 15-16kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100094-2 | | Trypanosoma cruzi 21-22kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100095-9 | | Trypanosoma cruzi 27-28kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100096-7 | | Trypanosoma cruzi 42kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100097-5 | | Trypanosoma cruzi 45-47kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100098-3 | | Trypanosoma cruzi 120-200kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100099-1 | | Trypanosoma cruzi 160kD IgG Ab [Presence] in Serum by Immunoblot | |
| 1001-7 | | DBG Ab [Presence] in Serum or Plasma from Donor | |
| 100100-7 | | Fasciola sp IgG Ab [Presence] in Serum by Immunoassay | |
| 100101-5 | | Fasciola sp 8-9kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100102-3 | | Fasciola sp 27-28kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100103-1 | | Fasciola sp 60kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100104-9 | | Fasciola sp 42kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100105-6 | | Filaria IgG and IgM panel - Serum | |
| 100106-4 | | Filaria IgG Ab [Presence] in Serum by Immunoassay | |
| 100107-2 | | Leishmania sp IgG Ab [Presence] in Serum by Immunoassay | |
| 100108-0 | | Leishmania sp IgG Ab [Units/volume] in Serum by Immunoassay | |
| 100109-8 | | Leishmania sp Ab bands panel - Serum by Immunoblot | |
| 100110-6 | | Leishmania sp 14kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100111-4 | | Leishmania sp 16kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100112-2 | | Fasciola sp Ab bands panel - Serum by Immunoblot | |
| 100113-0 | | Helicobacter pylori Ab panel - Serum | |
| 100114-8 | | Toxoplasma gondii 30kD Ab [Presence] in Serum by Immunoblot | |
| 100115-5 | | Toxoplasma gondii 31kD Ab [Presence] in Serum by Immunoblot | |
| 100116-3 | | Toxoplasma gondii 33kD Ab [Presence] in Serum by Immunoblot | |
| 100117-1 | | Toxoplasma gondii 40kD Ab [Presence] in Serum by Immunoblot | |
| 100118-9 | | Toxoplasma gondii 41kD Ab [Presence] in Serum by Immunoblot | |
| 100119-7 | | Toxoplasma gondii 45kD Ab [Presence] in Serum by Immunoblot | |
| 100120-5 | | Chlamydia trachomatis Ab panel - Serum | |
| 100121-3 | | Chlamydia trachomatis IgA Ab [Presence] in Serum by Immunoassay | |
| 100122-1 | | Chlamydophila pneumoniae Ab panel - Serum | |
| 100123-9 | | Chlamydophila pneumoniae IgA Ab [Presence] in Serum by Immunoassay | |
| 100124-7 | | Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum by Immunoassay | |
| 100125-4 | | Chlamydophila psittaci Ab panel - Serum | |
| 100126-2 | | Bordetella pertussis Ab.IgG panel - Serum | |
| 100127-0 | | Campylobacter sp Ab panel - Serum | |
| 100128-8 | | Cryptococcus sp Ag panel - Serum | |
| 100129-6 | | Schistosoma sp Ab [Titer] in Serum by Hemagglutination | |
| 100130-4 | | Schistosoma mansoni Ab [Presence] in Serum by Immunoblot | |
| 100131-2 | | Schistosoma sp 8kD Ab [Presence] in Serum by Immunoblot | |
| 100132-0 | | Schistosoma sp 9kD Ab [Presence] in Serum by Immunoblot | |
| 100133-8 | | Schistosoma sp 10kD Ab [Presence] in Serum by Immunoblot | |
| 100134-6 | | Schistosoma sp 11kD Ab [Presence] in Serum by Immunoblot | |
| 100135-3 | | Schistosoma sp 12-13kD Ab [Presence] in Serum by Immunoblot | |
| 100136-1 | | Schistosoma sp 14-15kD Ab [Presence] in Serum by Immunoblot | |
| 100137-9 | | Schistosoma sp 15-16kD Ab [Presence] in Serum by Immunoblot | |
| 100138-7 | | Schistosoma sp 18-19kD Ab [Presence] in Serum by Immunoblot | |
| 100139-5 | | Schistosoma sp 22-24kD Ab [Presence] in Serum by Immunoblot | |
| 100140-3 | | Schistosoma sp 30-34kD Ab [Presence] in Serum by Immunoblot | |
| 100141-1 | | Schistosoma sp 65kD Ab [Presence] in Serum by Immunoblot | |
| 100142-9 | | Schistosoma sp 70kD Ab [Presence] in Serum by Immunoblot | |
| 100143-7 | | Schistosoma sp 80kD Ab [Presence] in Serum by Immunoblot | |
| 100144-5 | | Schistosoma sp 95kD Ab [Presence] in Serum by Immunoblot | |
| 100145-2 | | Schistosoma sp 110kD Ab [Presence] in Serum by Immunoblot | |
| 100146-0 | | Schistosoma sp 120kD Ab [Presence] in Serum by Immunoblot | |
| 100147-8 | | Toxoplasma gondii Ab bands panel - Serum by Immunoblot | |
| 100148-6 | | Schistosoma sp Ab bands panel - Serum by Immunoblot | |
| 100149-4 | | 6-oxo-piperidine-2-carboxylate and 6(R+S)-oxo-propylpiperidine-2-carboxylate panel - Urine and Serum or Plasma | |
| 100150-2 | | 6(R+S)-oxo-propylpiperidine-2-carboxylate [Moles/volume] in Plasma | |
| 100151-0 | | 6-oxo-piperidine-2-carboxylate [Moles/volume] in Plasma | |
| 100152-8 | | 6-oxo-piperidine-2-carboxylate/Creatinine [Molar ratio] in Urine | |
| 100153-6 | | 6(R+S)-oxo-propylpiperidine-2-carboxylate/Creatinine [Molar ratio] in Urine | |
| 100154-4 | | Specimen collection supervision level | |
| 100156-9 | | SARS-CoV-2 (COVID-19) variant [Type] in Specimen by NAA with probe detection | |
| 100157-7 | | SARS-CoV-2 (COVID-19) lineage [Type] in Specimen by Sequencing | |
| 100158-5 | | Microalbumin [Mass/volume] in Urine collected for unspecified duration | |
| 100159-3 | | Knee Society Score pre-op panel [Knee Society Score] | |
| 100168-4 | | Knee pain severity with level walking | |
| 100169-2 | | Knee pain severity with stairs or inclines | |
| 100170-0 | | Knee feels normal | |
| 100171-8 | | Satisfaction with level of knee pain while sitting | |
| 100172-6 | | Satisfaction with level of knee pain while lying in bed | |
| 100173-4 | | Satisfaction with knee function while getting out of bed | |
| 100174-2 | | Satisfaction with knee function while performing light household duties | |
| 100175-9 | | Satisfaction with knee function while performing recreational activities | |
| 100176-7 | | Expect surgery to relieve pain | |
| 100177-5 | | Expect surgery will improve ability to perform activities of daily living | |
| 100178-3 | | Expect surgery will improve ability to perform leisure, recreational, or sports activities | |
| 100179-1 | | Walk without assistive mobility devices | |
| 100180-9 | | Assistive mobility devices used | |
| 100181-7 | | Assistive mobility devices used due to health condition | |
| 100182-5 | | Duration of standing before sitting due to knee discomfort | |
| 100183-3 | | Duration of walking before stopping due to knee discomfort | |
| 100184-1 | | How bothersome is knee when walking on an uneven surface | |
| 100185-8 | | How bothersome is knee when turning or pivoting leg | |
| 100186-6 | | How bothersome is knee when climbing up or down a flight of stairs | |
| 100187-4 | | How bothersome is knee when getting up from a low seat without armrests | |
| 100188-2 | | How bothersome is knee when getting into or out of a car | |
| 100189-0 | | How bothersome is knee when moving laterally | |
| 100190-8 | | How bothersome is knee when climbing a ladder or step stool | |
| 100191-6 | | How bothersome is knee when carrying a bag for one block | |
| 100192-4 | | How bothersome is knee when squatting | |
| 100193-2 | | How bothersome is knee when kneeling | |
| 100194-0 | | How bothersome is knee when running | |
| 100195-7 | | Pain severity--during activity | |
| 100196-5 | | Pre-op total score [Knee Society Score] | |
| 100197-3 | | Exercise activity and pain severity panel | |
| 100198-1 | | Pre-op objective knee indicators score [Knee Society Score] | |
| 100199-9 | | Pre-op symptoms score [Knee Society Score] | |
| 1002-5 | | DBG Ab [Presence] in Serum or Plasma | |
| 100200-5 | | Pre-op patient expectations score [Knee Society Score] | |
| 100201-3 | | Pre-op functional activities score [Knee Society Score] | |
| 100202-1 | | Pre-op discretionary knee activities score [Knee Society Score] | |
| 100203-9 | | Knee Society Score post-op panel [Knee Society Score] | |
| 100204-7 | | Accuracy of pre-surgery expectations of pain relief | |
| 100205-4 | | Accuracy of pre-surgery expectations to perform activities of daily living | |
| 100206-2 | | Accuracy of pre-surgery expectations to perform leisure, recreational, or sports activities | |
| 100207-0 | | Post-op total score [Knee Society Score] | |
| 100208-8 | | Post-op objective knee indicators score [Knee Society Score] | |
| 100209-6 | | Post-op symptoms score [Knee Society Score] | |
| 100210-4 | | Post-op patient expectations score [Knee Society Score] | |
| 100211-2 | | Post-op functional activities score [Knee Society Score] | |
| 100212-0 | | Post-op discretionary knee activities score [Knee Society Score] | |
| 100213-8 | | Prostate cancer multigene analysis in Blood or Tissue by Molecular genetics method | |
| 100232-8 | | Impacts of Events Scale-Revised panel | |
| 100233-6 | | Reminders brought back feelings about adverse event | |
| 100234-4 | | Trouble staying asleep | |
| 100235-1 | | Other things triggered persistent thoughts about adverse event | |
| 100236-9 | | Felt irritable AndOr angry | |
| 100237-7 | | Avoided getting upset when unintentionally thought about adverse event | |
| 100238-5 | | Thought about adverse event unintentionally | |
| 100239-3 | | Felt as if adverse event did not happen | |
| 100240-1 | | Avoided reminders of adverse event | |
| 100241-9 | | Experienced mental images of adverse event | |
| 100242-7 | | Easily startled | |
| 100243-5 | | Tried to not think of adverse event | |
| 100244-3 | | Aware of feelings about adverse event, but did not address them | |
| 100245-0 | | Feelings about adverse event were numb | |
| 100246-8 | | Acted or felt the same as during adverse event | |
| 100247-6 | | Trouble falling asleep | |
| 100248-4 | | Waves of strong feelings about adverse event | |
| 100249-2 | | Tried to remove adverse event from memory | |
| 100250-0 | | Trouble concentrating | |
| 100251-8 | | Reminders of adverse event caused physical reactions | |
| 100252-6 | | Had dreams about adverse event | |
| 100253-4 | | Felt watchful and on-guard | |
| 100254-2 | | Tried not to talk about adverse event | |
| 100255-9 | | Total score [Impact of Event Scale-Revised] | |
| 100259-1 | | Aware of tactile sensations | |
| 100260-9 | | Easy to describe thoughts AndOr feelings | |
| 100261-7 | | Critical of own thoughts AndOr feelings | |
| 100262-5 | | Able to notice distressing thoughts AndOr feelings without having to react | |
| 100263-3 | | Easily distracted | |
| 100264-1 | | Able to notice thoughts AndOr feelings without being overwhelmed | |
| 100265-8 | | Aware of dietary intake impact on self | |
| 100266-6 | | Difficult to describe thoughts AndOr feelings | |
| 100267-4 | | Aware of auditory stimuli | |
| 100268-2 | | Able to avoid immediate reaction in difficult situations | |
| 100269-0 | | Do things without paying attention | |
| 100270-8 | | Recover quickly from distressing thoughts AndOr images | |
| 100271-6 | | Aware of olfactory stimuli | |
| 100272-4 | | Aware of visual stimuli | |
| 100273-2 | | Aware of emotions affect on thoughts AndOr behavior | |
| 100274-0 | | Observing score [FFMQ] | |
| 100275-7 | | Describing score [FFMQ] | |
| 100276-5 | | Acting with awareness score [FFMQ] | |
| 100277-3 | | Nonjudging score [FFMQ] | |
| 100278-1 | | Nonreactivity score [FFMQ] | |
| 100279-9 | | Total score [FFMQ] | |
| 100280-7 | | Five Facet Mindfulness Questionnaire panel [FFMQ] | |
| 100281-5 | | D Ab [Units/volume] in Serum or Plasma | |
| 100283-1 | | Harris Hip Score panel [Harris Hip Score] | |
| 100284-9 | | Walking - functional ability | |
| 100285-6 | | Comfortable seated position | |
| 100286-4 | | Able to board public transportation | |
| 100287-2 | | Put on shoes and socks | |
| 100288-0 | | Absence of deformity score [Harris Hip Score] | |
| 100289-8 | | Absence of hip deformity measurements | |
| 100290-6 | | Range of motion score [Harris Hip Score] | |
| 100291-4 | | Total score [Harris Hip Score] | |
| 100292-2 | | Pre-op patient satisfaction score [Knee Society Score] | |
| 100293-0 | | Hip Flexion range of motion | |
| 100294-8 | | Hip Abduction range of motion | |
| 100295-5 | | Hip Adduction range of motion | |
| 100296-3 | | Hip External rotation range of motion | |
| 100297-1 | | Hip Internal rotation range of motion | |
| 100299-7 | | Post-op patient satisfaction score [Knee Society Score] | |
| 1003-3 | | Indirect antiglobulin test.complement specific reagent [Presence] in Serum or Plasma | |
| 100305-2 | | IDH1 gene exon 4 targeted mutation analysis [Presence] in Blood or Marrow by Molecular genetics method | |
| 100306-0 | | IDH2 gene exon 4 targeted mutation analysis [Presence] in Blood or Marrow by Molecular genetics method | |
| 100307-8 | | Behavioral screening elder mistreatment | |
| 100308-6 | | Need help getting to essential places | |
| 100309-4 | | Activity support person | |
| 100310-2 | | Reliability of support person | |
| 100311-0 | | Need help to make sure there is enough food, medicines or any other things needed in house | |
| 100312-8 | | Person or persons that makes sure there is enough food, medicines or any other things needed in house | |
| 100313-6 | | Need help with household things such as cook meals, help feed, or provide correct medicines each day | |
| 100314-4 | | Need help with house cleaning or yard work | |
| 100315-1 | | Need help getting out of bed, showered, or dressed | |
| 100316-9 | | Need help to make sure bills get paid | |
| 100317-7 | | Relationship of usual support person for daily activities | |
| 100318-5 | | Have help with finances AndOr financial decisions | |
| 100319-3 | | Relationship of financial support person | |
| 100320-1 | | Financial support person usually asks for permission before making decisions | |
| 100321-9 | | Financial support person usually makes good decisions about finances | |
| 100322-7 | | Have access to paperwork for financial decisions made | |
| 100323-5 | | Financial support person forged signature | |
| 100324-3 | | Coercion of financial support person for signing a document in order to get money or possessions | |
| 100325-0 | | Experienced theft by support person | |
| 100326-8 | | Money spent or property sold without permission | |
| 100327-6 | | Stranger forged signature for financial gain | |
| 100328-4 | | Stranger forced document signature for financial gain | |
| 100329-2 | | Feared for safety due to verbal attack | |
| 100330-0 | | Felt humiliated due to ridicule | |
| 100331-8 | | Coerced to do something | |
| 100332-6 | | Ignored by close friend or relative for extended period | |
| 100333-4 | | Physically hit or threatened | |
| 100334-2 | | Been physically hurt with some degree of injury | |
| 100335-9 | | Coerced sexual activity | |
| 100336-7 | | Coerced touching of private body parts of self or others | |
| 100337-5 | | Coerced to undress or expose private body area | |
| 100338-3 | | Photographed in any degree of nudity without consent | |
| 100339-1 | | Experienced attempted physical restraint | |
| 100340-9 | | Range of motion panel Hip | |
| 100341-7 | | Rubella virus IgG Ab index [Units/volume] in Serum and CSF | |
| 100342-5 | | Volatile Organic Compounds associated with SARS-CoV-2 infection [Presence] in Exhaled gas by Gas chromatography-mass spectrometry | |
| 100343-3 | | Influenza virus B RNA [Presence] in Saliva (oral fluid) by NAA with probe detection | |
| 100344-1 | | Influenza virus A RNA [Presence] in Saliva (oral fluid) by NAA with probe detection | |
| 100345-8 | | Influenza virus A and B and SARS-CoV-2 (COVID-19) RNA panel - Specimen by NAA with probe detection | |
| 100346-6 | | Clotting time.extrinsic coagulation system activated.platelets inhibited of Blood by Rotational TEG | |
| 100347-4 | | Clot formation.extrinsic coagulation system activated.platelets inhibited [Time] in Blood by Rotational TEG | |
| 100350-8 | | Sesamum indicum 1 IgE Ab [Units/volume] in Serum | |
| 100351-6 | | Pioglitazone [Presence] in Serum or Plasma | |
| 100352-4 | | Rosiglitazone [Presence] in Serum or Plasma | |
| 100353-2 | | Norwalk Community Health Center Screening Tool [NCHC] | |
| 100354-0 | | Frequency of participating in multi-modal communication without assistance | |
| 100355-7 | | Frequency of participating in spoken language expression communication without assistance | |
| 100356-5 | | Chlamydia trachomatis and Neisseria gonorrhoeae and Trichomonas vaginalis DNA [Identifier] in Specimen by NAA with probe detection | |
| 100357-3 | | Naloxone [Presence] in Cord tissue by Screen method | |
| 100358-1 | | Phentermine [Presence] in Cord tissue by Screen method | |
| 100359-9 | | Gliadin 33 mer peptide [Mass/volume] in Stool by Immunoassay | |
| 100360-7 | | Brief Resilience Scale panel [BRS] | |
| 100361-5 | | Quickly recover from bad events | |
| 100362-3 | | Difficulty making it through stressful events | |
| 100363-1 | | Easily recover from a stressful event | |
| 100364-9 | | Difficulty recovering from bad events | |
| 100365-6 | | Easily recover from difficulties | |
| 100366-4 | | Lengthy recovery from setbacks | |
| 100367-2 | | Total Score BRS | |
| 100368-0 | | Amino Acids Urea Cycle Panel - Serum or Plasma by LC/MS/MS | |
| 100370-6 | | Orthopoxvirus DNA [Identifier] in Specimen by NAA with probe detection | |
| 100371-4 | | Titin Ab [Units/volume] in Serum by Immunoassay | |
| 100372-2 | | Abiraterone [Mass/volume] in Serum or Plasma | |
| 100373-0 | | Eucheuma IgG Ab [Units/volume] in Serum | |
| 100374-8 | | Aloe vera IgG Ab [Units/volume] in Serum | |
| 100375-5 | | Anise IgG Ab [Units/volume] in Serum | |
| 100376-3 | | Bambusa vulgaris IgG Ab [Units/volume] in Serum | |
| 100377-1 | | Goat cheese IgG Ab [Units/volume] in Serum | |
| 100378-9 | | Sheep cheese IgG Ab [Units/volume] in Serum | |
| 100379-7 | | Leeks IgG Ab [Units/volume] in Serum | |
| 100380-5 | | Red cabbage IgG Ab [Units/volume] in Serum | |
| 100381-3 | | Mentha balsamea Wild IgG Ab [Units/volume] in Serum | |
| 100383-9 | | Monkeypox virus DNA [Presence] in Specimen by NAA with probe detection | |
| 100384-7 | | Rapeseed IgG Ab [Units/volume] in Serum | |
| 100385-4 | | Corn salad IgG Ab [Units/volume] in Serum | |
| 100386-2 | | Rosemary IgG Ab [Units/volume] in Serum | |
| 100387-0 | | Poppy Seed IgG Ab [Units/volume] in Serum | |
| 100388-8 | | Cocoa IgG Ab [Units/volume] in Serum | |
| 100389-6 | | Pistachio IgG Ab [Units/volume] in Serum | |
| 100390-4 | | Sunflower Seed IgG Ab [Units/volume] in Serum | |
| 100391-2 | | Dates IgG Ab [Units/volume] in Serum | |
| 100392-0 | | Duck meat IgG Ab [Units/volume] in Serum | |
| 100393-8 | | Allergen Mushroom mix 2 (Xerocomus, Boletus) IgG Ab [Units/volume] in Serum | |
| 100394-6 | | Astacoidea IgG Ab [Units/volume] in Serum | |
| 100395-3 | | Carob IgG Ab [Units/volume] in Serum | |
| 100396-1 | | Brassica napus IgG Ab [Units/volume] in Serum | |
| 100397-9 | | Goat Meat IgG Ab [Units/volume] in Serum | |
| 100398-7 | | Goose meat IgG Ab [Units/volume] in Serum | |
| 100399-5 | | Ostrich meat IgG Ab [Units/volume] in Serum | |
| 1004-1 | | Direct antiglobulin test.complement specific reagent [Presence] on Red Blood Cells | |
| 100400-1 | | Quail meat IgG Ab [Units/volume] in Serum | |
| 100401-9 | | Rabbit meat IgG Ab [Units/volume] in Serum | |
| 100402-7 | | Venison meat IgG Ab [Units/volume] in Serum | |
| 100403-5 | | Guineafowl IgG Ab [Units/volume] in Serum | |
| 100404-3 | | Horse meat IgG Ab [Units/volume] in Serum | |
| 100405-0 | | Kefir IgG Ab [Units/volume] in Serum | |
| 100406-8 | | Butter IgG Ab [Units/volume] in Serum | |
| 100407-6 | | Camembert cheese IgG Ab [Units/volume] in Serum | |
| 100408-4 | | Emmental cheese IgG Ab [Units/volume] in Serum | |
| 100409-2 | | Processed cheese IgG Ab [Units/volume] in Serum | |
| 100410-0 | | Curd cheese IgG Ab [Units/volume] in Serum | |
| 100411-8 | | Sugar Beet IgG Ab [Units/volume] in Serum | |
| 100412-6 | | Chinese cabbage IgG Ab [Units/volume] in Serum | |
| 100413-4 | | Fennel Fresh IgG Ab [Units/volume] in Serum | |
| 100414-2 | | Gourd IgG Ab [Units/volume] in Serum | |
| 100415-9 | | Kale IgG Ab [Units/volume] in Serum | |
| 100416-7 | | Savoy cabbage IgG Ab [Units/volume] in Serum | |
| 100417-5 | | Vitis sp leaf IgG Ab [Units/volume] in Serum | |
| 100418-3 | | Liquorice IgG Ab [Units/volume] in Serum | |
| 100419-1 | | Snow pea IgG Ab [Units/volume] in Serum | |
| 100420-9 | | Fava bean IgG Ab [Units/volume] in Serum | |
| 100421-7 | | Chick Pea IgG Ab [Units/volume] in Serum | |
| 100422-5 | | Chicory IgG Ab [Units/volume] in Serum | |
| 100423-3 | | Allergy Mushroom Mix 1 (Button + oyster + Shiitaki + chanterelle mushroom) IgG Ab [Units/volume] in Serum | |
| 100424-1 | | 8(9)-Cholestenol [Mass/volume] in Serum or Plasma | |
| 100425-8 | | DiHydro T-Mas [Mass/volume] in Serum or Plasma | |
| 100426-6 | | Squalene [Mass/volume] in Serum or Plasma | |
| 100427-4 | | Stigmasterol [Mass/volume] in Serum or Plasma | |
| 100428-2 | | Carnitine free and total and acylcarnitine panel - Urine | |
| 100429-0 | | LRBA deficiency panel - Blood | |
| 100430-8 | | Cells.LRBA+/100 Cells.CD3+CD14-CD45+ in Blood by Flow cytometry (FC) | |
| 100431-6 | | Cells.CD3+CD14-CD45+.LRBA mean fluorescence intensity in Blood by Flow cytometry (FC) | |
| 100432-4 | | Cells.LRBA+/100 Cells.CD3-CD14-CD19+CD45+ in Blood by Flow cytometry (FC) | |
| 100433-2 | | Cells.CD3-CD14-CD19+CD45+.LRBA mean fluorescence intensity in Blood by Flow cytometry (FC) | |
| 100434-0 | | Orthopoxvirus.non-variola DNA [Presence] in Specimen by NAA with probe detection | |
| 100435-7 | | Glial fibrillary acidic protein [Mass/volume] in Serum by Immunoassay | |
| 100436-5 | | Ubiquitin carboxyl-terminal hydrolase-L1 [Mass/volume] in Serum by Immunoassay | |
| 100437-3 | | Norsufentanil [Mass/volume] in Urine by Confirmatory method | |
| 1005-8 | | Indirect antiglobulin test.IgG specific reagent [Presence] in Serum or Plasma | |
| 1006-6 | | Direct antiglobulin test.IgG specific reagent [Interpretation] on Red Blood Cells | |
| 100654-3 | | Pyruvate kinase M2 [Presence] in Stool | |
| 100662-6 | | Cortisol free and total panel - Serum or Plasma | |
| 100663-4 | | TPMT gene c.460G>A and c.719A>G [Presence] in Blood by Molecular genetics method | |
| 100664-2 | | NUDT15 gene c.50_55dup and c.415C>T [Presence] in Blood by Molecular genetics method | |
| 100665-9 | | NUDT15 gene c.415C>T [Presence] in Blood by Molecular genetics method | |
| 100666-7 | | NUDT15 gene c.416G>A [Presence] in Blood by Molecular genetics method | |
| 100667-5 | | NUDT15 gene c.52G>A [Presence] in Blood by Molecular genetics method | |
| 100668-3 | | NUDT15 gene c.50_55dup [Presence] in Blood by Molecular genetics method | |
| 100669-1 | | NUDT15 gene c.50_55del [Presence] in Blood by Molecular genetics method | |
| 100670-9 | | RHD gene allele [Identifier] in Plasma cell-free DNA Nominal--fetus | |
| 100671-7 | | Aspergillus sp DNA [Presence] in Blood by NAA with probe detection | |
| 100672-5 | | Aspergillus fumigatus DNA [Presence] in Blood by NAA with probe detection | |
| 100673-3 | | Aspergillus terreus DNA [Presence] in Blood by NAA with probe detection | |
| 100674-1 | | BK virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection | |
| 100675-8 | | Cytomegalovirus DNA [Units/volume] (viral load) in Blood by NAA with probe detection | |
| 100676-6 | | Cytomegalovirus DNA [log units/volume] (viral load) in Blood by NAA with probe detection | |
| 100677-4 | | Epstein Barr virus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection | |
| 100678-2 | | Epstein Barr virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection | |
| 100679-0 | | Herpes virus 6 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection | |
| 100680-8 | | Herpes virus 6 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection | |
| 100681-6 | | Herpes virus 7 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection | |
| 100682-4 | | Herpes virus 7 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection | |
| 100683-2 | | Herpes virus 8 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection | |
| 100684-0 | | Herpes virus 8 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection | |
| 100685-7 | | JC virus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection | |
| 100686-5 | | JC virus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection | |
| 100687-3 | | JC virus DNA [Log #/volume] (viral load) in Urine by NAA with probe detection | |
| 100688-1 | | Parvovirus B19 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection | |
| 100689-9 | | Toxoplasma gondii DNA [Log #/volume] in Serum or Plasma by NAA with probe detection | |
| 100690-7 | | Toxoplasma gondii DNA [Log #/volume] in Cerebral spinal fluid by NAA with probe detection | |
| 100691-5 | | Varicella zoster virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection | |
| 100692-3 | | Varicella zoster virus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection | |
| 100693-1 | | Pneumocystis jiroveci DNA [Log #/volume] in Respiratory specimen by NAA with probe detection | |
| 100694-9 | | SMN1 gene silent carrier analysis [Presence] in Blood or Tissue by Molecular genetics method | |
| 100695-6 | | Genetic disease analysis overall carrier interpretation in Blood or Tissue by Molecular genetics method Narrative | |
| 100696-4 | | CTNS related multigene analysis [Identifier] in Bodyfluid and Serum or Plasma by Molecular genetics method Nominal | |
| 100699-8 | | Rifabutin+Ethambutol [Susceptibility] | |
| 1007-4 | | Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells | |
| 100700-4 | | Trichomonas vaginalis DNA [Presence] in Urethra by NAA with probe detection | |
| 100701-2 | | Trichomonas vaginalis rRNA [Presence] in Urethra by NAA with probe detection | |
| 100702-0 | | Mycoplasma genitalium rRNA [Presence] in Urethra by NAA with probe detection | |
| 100703-8 | | Mycoplasma genitalium rRNA [Presence] in Urine by NAA with probe detection | |
| 100704-6 | | Mycoplasma genitalium rRNA [Presence] in Cervix by NAA with probe detection | |
| 100705-3 | | Mycoplasma genitalium rRNA [Presence] in Anorectal by NAA with probe detection | |
| 100706-1 | | Mycoplasma genitalium rRNA [Presence] in Specimen by NAA with probe detection | |
| 100707-9 | | Polymorphonuclear cells [#/volume] in Peritoneal dialysis fluid by Automated count | |
| 100708-7 | | Plasma cells/100 leukocytes in Synovial fluid | |
| 100709-5 | | Hepatocellular carcinoma risk [Score] by GAAD | |
| 100710-3 | | Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Throat by NAA with probe detection | |
| 100711-1 | | Borrelia burgdorferi.VlsE1+pepC10 Ab [Units/volume] in Serum by Immunoassay | |
| 100712-9 | | Brexpiprazole [Mass/volume] in Serum or Plasma | |
| 100713-7 | | Cariprazine [Mass/volume] in Serum or Plasma | |
| 100714-5 | | Guanfacine [Mass/volume] in Serum or Plasma | |
| 100715-2 | | Prothipendyl [Mass/volume] in Serum or Plasma | |
| 100716-0 | | Prostate specific Ag [Mass/volume] in DBS | |
| 100717-8 | | FCGR3A gene.p.Phe176Val [Presence] in Blood or Tissue by Molecular genetics method | |
| 100732-7 | | Cholesterol.in lipoprotein (little a) and Cholesterol.in LDL panel - Serum | |
| 100733-5 | | Cholesterol in LDL [Mass/volume] in Serum by calculation --corrected for Cholesterol.in lipoprotein (little a) | |
| 100734-3 | | traMADol and Metabolites Panel - Urine by Confirmatory method | |
| 100735-0 | | Mannose-6-phosphate isomerase and phosphomannomutase 1 panel - Leukocytes | |
| 100736-8 | | Acylcarnitine Analysis Post Mortem in Specimen Document | |
| 100737-6 | | Alkaline phosphatase.macromolecular [Presence] in Serum or Plasma | |
| 100738-4 | | Alanine aminotransferase.macromolecular [Presence] in Serum or Plasma | |
| 100739-2 | | Aspartate aminotransferase.macromolecular [Presence] in Serum or Plasma | |
| 100740-0 | | Amylase.macromolecular [Presence] in Serum or Plasma | |
| 100741-8 | | Gamma glutamyl transferase.macromolecular [Presence] in Serum or Plasma | |
| 100742-6 | | Lactate dehydrogenase.macromolecular [Presence] in Serum or Plasma | |
| 100743-4 | | Lipase.macromolecular [Presence] in Serum or Plasma | |
| 100744-2 | | Alpha-1-acid glycoprotein [Mass/volume] in Serum or Plasma by Electrophoresis | |
| 100745-9 | | Chloride [Moles/volume] in Mixed venous blood | |
| 100746-7 | | Glucose [Moles/volume] in Mixed venous blood | |
| 100747-5 | | Legionella serogroup panel - Specimen | |
| 100748-3 | | Legionella spp [Presence] in Specimen by NAA with probe detection | |
| 100749-1 | | Legionella pneumophila serogroup 1 [Presence] in Specimen by NAA with probe detection | |
| 100750-9 | | Legionella pneumophila non-serogroup 1 [Presence] in Specimen by NAA with probe detection | |
| 100751-7 | | Galactose-alpha-1,3-galactose (Alpha-Gal) panel - Serum or Plasma | |
| 100754-1 | | Platelet disorders multigene analysis in Blood or Tissue by Sequencing | |
| 100755-8 | | Oligoclonal bands [#] in Serum or Plasma by Isoelectric focusing | |
| 100756-6 | | Oligoclonal bands [Interpretation] in Cerebral spinal fluid by Isoelectric focusing | |
| 100757-4 | | Protein fractions.oligoclonal bands panel - Serum and CSF by Isoelectric focusing | |
| 100761-6 | | PALB2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method | |
| 100762-4 | | HBA2 gene.c.377T>C [Presence] in Blood by Molecular genetics method | |
| 100763-2 | | Mycobacterium sp comparative reaction interpretation Narrative | |
| 100764-0 | | Mycobacterium bovis reaction wheal [Diameter] Qualitative --3 days post dose mammalian tuberculin intradermal | |
| 100765-7 | | Homocysteine and methylmalonate and methylcitrate panel - DBS | |
| 100766-5 | | Center for Epidemiologic Studies Depression Scale panel [CES-D] | |
| 100767-3 | | Bothered by things that are not usually bothersome | |
| 100768-1 | | Poor appetite | |
| 100769-9 | | Unhappy even with help from my family or friends | |
| 100770-7 | | Feeling just as good as others | |
| 100771-5 | | Trouble focusing | |
| 100772-3 | | Feeling depressed | |
| 100773-1 | | Feeling everything is too much of an effort | |
| 100774-9 | | Feeling hopeful about the future | |
| 100775-6 | | Feeling life had been a failure | |
| 100776-4 | | Feeling fearful | |
| 100777-2 | | Restless sleep | |
| 100778-0 | | Feeling happy | |
| 100779-8 | | Quieter than usual | |
| 100780-6 | | Feeling lonely | |
| 100781-4 | | People were unfriendly | |
| 100782-2 | | Enjoying life | |
| 100783-0 | | Crying spells | |
| 100784-8 | | Feeling sad | |
| 100785-5 | | Feeling people dislike me | |
| 100786-3 | | Lack of energy | |
| 100787-1 | | Total Score CES-D | |
| 100788-9 | | Stemphylium botryosum IgG4 Ab [Mass/volume] in Serum | |
| 100789-7 | | Rhizopus nigricans IgG4 Ab [Mass/volume] in Serum | |
| 100790-5 | | Lepidoglyphus destructor IgG Ab [Mass/volume] in Serum | |
| 100791-3 | | Hamster epithelium IgG Ab [Mass/volume] in Serum | |
| 100792-1 | | Forsythia IgE Ab [Units/volume] in Serum | |
| 100793-9 | | Testosterone [Mass/volume] in Body fluid | |
| 100794-7 | | Follitropin [Units/volume] in Body fluid | |
| 100795-4 | | S100 calcium binding protein B [Mass/volume] in Body fluid | |
| 100796-2 | | Thyroglobulin [Mass/volume] in Body fluid | |
| 100797-0 | | Testosterone Free [Mass/volume] in Serum --1st specimen post XXX challenge | |
| 100798-8 | | Testosterone Free [Mass/volume] in Serum --2nd specimen post XXX challenge | |
| 100799-6 | | 21-Deoxycortisol [Mass/volume] in Serum --1st specimen post XXX challenge | |
| 1008-2 | | Indirect antiglobulin test.polyspecific reagent [Presence] in Serum or Plasma | |
| 100800-2 | | 21-Deoxycortisol [Mass/volume] in Serum --2nd specimen post XXX challenge | |
| 100801-0 | | 21-Deoxycortisol [Mass/volume] in Serum --3rd specimen post XXX challenge | |
| 100802-8 | | 21-Deoxycortisol [Mass/volume] in Serum --4th specimen post XXX challenge | |
| 100803-6 | | 21-Deoxycortisol [Mass/volume] in Serum --5th specimen post XXX challenge | |
| 100804-4 | | Vasopressin [Moles/volume] in Plasma --1st specimen post XXX challenge | |
| 100805-1 | | Vasopressin [Moles/volume] in Plasma --2nd specimen post XXX challenge | |
| 100806-9 | | Vasopressin [Moles/volume] in Plasma --3rd specimen post XXX challenge | |
| 100807-7 | | Vasopressin [Moles/volume] in Plasma --4th specimen post XXX challenge | |
| 100808-5 | | Vasopressin [Moles/volume] in Plasma --5th specimen post XXX challenge | |
| 100809-3 | | Vasopressin [Moles/volume] in Plasma --6th specimen post XXX challenge | |
| 100810-1 | | Vasopressin [Moles/volume] in Plasma --7th specimen post XXX challenge | |
| 100811-9 | | Vasopressin [Moles/volume] in Plasma --8th specimen post XXX challenge | |
| 100812-7 | | Vasopressin [Moles/volume] in Plasma --9th specimen post XXX challenge | |
| 100813-5 | | Vasopressin [Moles/volume] in Plasma --10th specimen post XXX challenge | |
| 100814-3 | | Vasopressin [Moles/volume] in Plasma --11th specimen post XXX challenge | |
| 100815-0 | | Vasopressin [Moles/volume] in Plasma --12th specimen post XXX challenge | |
| 100816-8 | | Glucagon [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge | |
| 100817-6 | | Glucagon [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge | |
| 100818-4 | | Renin [Mass/volume] in Plasma --1st specimen post XXX challenge | |
| 100819-2 | | Renin [Mass/volume] in Plasma --2nd specimen post XXX challenge | |
| 100820-0 | | Renin [Mass/volume] in Plasma --3rd specimen post XXX challenge | |
| 100829-1 | | Renin [Mass/volume] in Plasma --4th specimen post XXX challenge | |
| 100830-9 | | Alpha subunit free [Units/volume] in Serum or Plasma --1st specimen post XXX challenge | |
| 100831-7 | | Alpha subunit free [Units/volume] in Serum or Plasma --2nd specimen post XXX challenge | |
| 100832-5 | | Alpha subunit free [Units/volume] in Serum or Plasma --3rd specimen post XXX challenge | |
| 100833-3 | | Alpha subunit free [Units/volume] in Serum or Plasma --4th specimen post XXX challenge | |
| 100834-1 | | Alpha subunit free [Units/volume] in Serum or Plasma --5th specimen post XXX challenge | |
| 100835-8 | | Alpha subunit free [Units/volume] in Serum or Plasma --6th specimen post XXX challenge | |
| 100836-6 | | Alpha subunit free [Units/volume] in Serum or Plasma --7th specimen post XXX challenge | |
| 100837-4 | | Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge | |
| 100838-2 | | Testosterone [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge | |
| 100839-0 | | Vitamin A/Retinol binding protein [Ratio] in Serum or Plasma | |
| 100840-8 | | IgE [Units/volume] in Body fluid | |
| 100841-6 | | Zinc finger protein of the cerebellum 4 Ab [Presence] in Cerebral spinal fluid by Line blot | |
| 100842-4 | | Nonalcoholic steatohepatitis score in Serum or Plasma Calculated by FAST | |
| 100843-2 | | Liver fibrosis score in Serum or Plasma by Calculated.Agile3+ | |
| 100844-0 | | Liver fibrosis score in Serum or Plasma by Calculated.Agile4 | |
| 100845-7 | | Neurofascin155 IgG4 Ab [Presence] in Serum by Flow cytometry (FC) | |
| 100846-5 | | Dengue virus 1+2+3+4 nsP1 IgG Ab [Presence] in Serum or Plasma by Immunoassay | |
| 100847-3 | | Gas and ammonia panel - Arterial blood | |
| 100848-1 | | Cell count and Differential panel - Amniotic fluid by Manual count | |
| 100849-9 | | Leukocytes [#/volume] in Amniotic fluid by Manual count | |
| 100850-7 | | Neutrophils [#/volume] in Amniotic fluid by Manual count | |
| 100851-5 | | Other cells [#/volume] in Amniotic fluid by Manual count | |
| 100854-9 | | Lymphocytes/100 cells in Blood mononuclear cells by Immunoassay | |
| 100855-6 | | CD3 cells/100 cells in Blood mononuclear cells | |
| 100856-4 | | CD3+CD4+ (T4 helper) cells/100 cells in Blood mononuclear cells | |
| 100857-2 | | CD3+CD8+ (T8 suppressor) cells/100 cells in Blood mononuclear cells | |
| 100858-0 | | Cells.CD4+CD154+/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide | |
| 100859-8 | | Cells.CD4.Interferon gamma-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide | |
| 100860-6 | | Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide | |
| 100861-4 | | Cells.CD4+CD154+/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide | |
| 100862-2 | | Cells.CD4.Interferon gamma-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide | |
| 100863-0 | | Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide | |
| 100864-8 | | Giardia lamblia bg gene [Genotype] in Specimen by Molecular genetics method | |
| 100865-5 | | Avian schistosomes DNA [Presence] in Specimen by NAA with probe detection | |
| 100866-3 | | Febrile antibody profile in Serum | |
| 100867-1 | | Campylobacter jejuni+coli+lari+upsaliensis Ag [Presence] in Stool by Rapid immunoassay | |
| 100868-9 | | Cryptosporidium sp 18S-LC2 rRNA [Genotype] in Specimen by Molecular genetics method | |
| 100869-7 | | Cryptosporidium gp60 gene [Type] in Specimen by Molecular genetics method | |
| 100870-5 | | Cryptosporidium 18S rRNA [Genotype] in Specimen by Molecular genetics method | |
| 100871-3 | | Giardia lamblia gdh gene [Genotype] in Specimen by Molecular genetics method | |
| 100872-1 | | Bacteria producing polysaccharide from sucrose [Presence] in Isolate | |
| 100873-9 | | Giardia lamblia tpi gene [Genotype] in Specimen by Molecular genetics method | |
| 100874-7 | | Basidiobolus sp [Presence] in Specimen | |
| 100885-3 | | Parapoxvirus DNA [Presence] in Specimen by NAA with probe detection | |
| 100886-1 | | Orf virus DNA [Presence] in Specimen by NAA with probe detection | |
| 100887-9 | | Pseudocowpox virus DNA [Presence] in Specimen by NAA with probe detection | |
| 100888-7 | | Monkeypox virus clade II DNA [Presence] in Specimen by NAA with probe detection | |
| 100889-5 | | Monkeypox virus clade I DNA [Presence] in Specimen by NAA with probe detection | |
| 100890-3 | | Poxvirus DNA panel | |
| 100891-1 | | Orthopoxvirus IgG Ab [Presence] in Serum or Plasma by Immunoassay | |
| 100892-9 | | Orthopoxvirus IgM Ab [Presence] in Serum or Plasma by Immunoassay | |
| 100893-7 | | Orthopoxvirus IgG and IgM Ab panel - Serum or Plasma | |
| 100895-2 | | Rickettsia conorii IgG and IgM [Interpretation] in Serum | |
| 100896-0 | | Vasopressin [Moles/volume] in Plasma --13th specimen post XXX challenge | |
| 100897-8 | | Staphylococcus aureus [Presence] in Specimen by Organism specific culture | |
jurisdiction[0]